<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Chronic Stress (Thousand Oaks)</journal-id>
<journal-id journal-id-type="iso-abbrev">Chronic Stress (Thousand Oaks)</journal-id>
<journal-id journal-id-type="publisher-id">CSS</journal-id>
<journal-id journal-id-type="hwp">spcss</journal-id>
<journal-title-group>
<journal-title>Chronic Stress</journal-title>
</journal-title-group>
<issn pub-type="epub">2470-5470</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32518889</article-id>
<article-id pub-id-type="pmc">7254587</article-id>
<article-id pub-id-type="doi">10.1177/2470547020924844</article-id>
<article-id pub-id-type="publisher-id">10.1177_2470547020924844</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Heterogeneity and Polygenicity in Psychiatric Disorders: A Genome-Wide Perspective</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-2108-6822</contrib-id>
<name>
<surname>Wendt</surname>
<given-names>Frank R.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pathak</surname>
<given-names>Gita A.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-7579-6096</contrib-id>
<name>
<surname>Tylee</surname>
<given-names>Daniel S.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goswami</surname>
<given-names>Aranyak</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-0745-6046</contrib-id>
<name>
<surname>Polimanti</surname>
<given-names>Renato</given-names>
</name>
<xref ref-type="corresp" rid="corresp1-2470547020924844"></xref>
</contrib>
<aff id="aff1-2470547020924844">Department of Psychiatry, Yale School of Medicine and VA CT Healthcare Center, West Haven, CT, USA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-2470547020924844">Renato Polimanti, Department of Psychiatry, Yale University School of Medicine, VA CT 116A2, 950 Campbell Avenue, West Haven, CT 06516, USA. Email: <email>renato.polimanti@yale.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<season>Jan-Dec</season>
<year>2020</year>
</pub-date>
<volume>4</volume>
<elocation-id>2470547020924844</elocation-id>
<history>
<date date-type="received">
<day>3</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder content-type="society">SAGE Publications Inc unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder>
<license license-type="creative-commons" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Genome-wide association studies (GWAS) have been performed for many psychiatric disorders and revealed a complex polygenic architecture linking mental and physical health phenotypes. Psychiatric diagnoses are often heterogeneous, and several layers of trait heterogeneity may contribute to detection of genetic risks per disorder or across multiple disorders. In this review, we discuss these heterogeneities and their consequences on the discovery of risk loci using large-scale genetic data. We primarily highlight the ways in which sex and diagnostic complexity contribute to risk locus discovery in schizophrenia, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, posttraumatic stress disorder, major depressive disorder, obsessive-compulsive disorder, Tourette’s syndrome and chronic tic disorder, anxiety disorders, suicidality, feeding and eating disorders, and substance use disorders. Genetic data also have facilitated discovery of clinically relevant subphenotypes also described here. Collectively, GWAS of psychiatric disorders revealed that the understanding of heterogeneity, polygenicity, and pleiotropy is critical to translate genetic findings into treatment strategies.</p>
</abstract>
<kwd-group>
<kwd>psychiatric disorders</kwd>
<kwd>heterogeneity</kwd>
<kwd>polygenicity</kwd>
<kwd>genome-wide association studies</kwd>
</kwd-group>
<funding-group>
<award-group id="award1-2470547020924844">
<funding-source id="funding1-2470547020924844">
<institution-wrap>
<institution>National Center for Posttraumatic Stress Disorder </institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="award2-2470547020924844">
<funding-source id="funding2-2470547020924844">
<institution-wrap>
<institution>National Institute on Deafness and Other Communication Disorders</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000055</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="award3-2470547020924844">
<funding-source id="funding3-2470547020924844">
<institution-wrap>
<institution>National Institute on Drug Abuse</institution>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000026</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-December 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>typesetter</meta-name>
<meta-value>ts2</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec1-2470547020924844" sec-type="intro">
<title>Introduction</title>
<p>Genome-wide association studies (GWAS) are powerful tools for risk allele and gene discovery when applied to complex traits.<sup><xref ref-type="bibr" rid="bibr1-2470547020924844">1</xref></sup> The resulting data enable investigation of biological mechanisms, pathways, tissues, and cell types relevant for phenotype etiology,<sup><xref ref-type="bibr" rid="bibr2-2470547020924844">2</xref><xref ref-type="bibr" rid="bibr3-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr4-2470547020924844">4</xref></sup> evolutionary pressures shaping genetic risk for a trait in the general population,<sup><xref ref-type="bibr" rid="bibr5-2470547020924844">5</xref><xref ref-type="bibr" rid="bibr6-2470547020924844"></xref><xref ref-type="bibr" rid="bibr7-2470547020924844"></xref><xref ref-type="bibr" rid="bibr8-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr9-2470547020924844">9</xref></sup> and correlation and causal inference between traits.<sup><xref ref-type="bibr" rid="bibr10-2470547020924844">10</xref><xref ref-type="bibr" rid="bibr11-2470547020924844"></xref><xref ref-type="bibr" rid="bibr12-2470547020924844"></xref><xref ref-type="bibr" rid="bibr13-2470547020924844"></xref><xref ref-type="bibr" rid="bibr14-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr15-2470547020924844">15</xref></sup></p>
<p>In psychiatry, GWAS have uncovered a high degree of polygenicity underlying mental illnesses and related complex phenotypes.<sup><xref ref-type="bibr" rid="bibr8-2470547020924844">8</xref>,<xref ref-type="bibr" rid="bibr16-2470547020924844">16</xref><xref ref-type="bibr" rid="bibr17-2470547020924844"></xref><xref ref-type="bibr" rid="bibr18-2470547020924844"></xref><xref ref-type="bibr" rid="bibr19-2470547020924844"></xref><xref ref-type="bibr" rid="bibr20-2470547020924844"></xref><xref ref-type="bibr" rid="bibr21-2470547020924844"></xref><xref ref-type="bibr" rid="bibr22-2470547020924844"></xref><xref ref-type="bibr" rid="bibr23-2470547020924844"></xref><xref ref-type="bibr" rid="bibr24-2470547020924844"></xref><xref ref-type="bibr" rid="bibr25-2470547020924844"></xref><xref ref-type="bibr" rid="bibr26-2470547020924844"></xref><xref ref-type="bibr" rid="bibr27-2470547020924844"></xref><xref ref-type="bibr" rid="bibr28-2470547020924844"></xref><xref ref-type="bibr" rid="bibr29-2470547020924844"></xref><xref ref-type="bibr" rid="bibr30-2470547020924844"></xref><xref ref-type="bibr" rid="bibr31-2470547020924844"></xref><xref ref-type="bibr" rid="bibr32-2470547020924844"></xref><xref ref-type="bibr" rid="bibr33-2470547020924844"></xref><xref ref-type="bibr" rid="bibr34-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr35-2470547020924844">35</xref></sup> Polygenicity describes the contribution of many single nucleotide polymorphisms (SNPs) with relatively small effect sizes to phenotype development. This phenomenon is ubiquitously observed in psychiatric disorders and comorbid phenotypes, as evidenced by the detection of tens to hundreds of genome-wide significant (GWS) linkage disequilibrium (LD) independent loci.<sup><xref ref-type="bibr" rid="bibr1-2470547020924844">1</xref></sup> Additionally, omnigenic models of complex traits suggest that highly interconnected gene regulatory networks influence trait etiology through a set of core genes and their associated regulatory elements and members of similar protein pathways.<sup><xref ref-type="bibr" rid="bibr36-2470547020924844">36</xref></sup></p>
<p>Though rare and structural variation contribute to the genetic liability of psychiatric disorders,<sup><xref ref-type="bibr" rid="bibr37-2470547020924844">37</xref><xref ref-type="bibr" rid="bibr38-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr39-2470547020924844">39</xref></sup> the magnitude and ubiquity of GWAS data limit the scope of this review to common genetic variation. Here, we discuss GWAS-based methods for interrogating the etiology of psychiatric disorders. Next, we describe the polygenic nature of psychiatric disorders and how genetic and phenotype heterogeneity may affect our ability to detect risk loci for these traits. Finally, we briefly discuss future directions for the field of psychiatric genomics, including the advantage of large GWAS consortia and biobanks for exploring phenotype heterogeneity using genetic data.</p>
</sec>
<sec id="sec2-2470547020924844">
<title>GWAS for Detecting the Polygenic Architecture of Psychiatric Disorders</title>
<p>The primary goal of human genetics is to identify risk and protective factors for disease. Many aspects of human health and disease pose a challenge toward this goal. Complex traits lack a single gene with large enough effects to study in singularity with generalizable findings. Conversely, GWAS of complex traits have revealed large degrees of polygenicity underlying mental health (i.e. psychiatric disorders, behavior, personality traits, social science traits, and brain region measurements).<sup><xref ref-type="bibr" rid="bibr1-2470547020924844">1</xref></sup> GWAS are hypothesis-generating experiments that detect relationships between allele frequency and categorical or quantitative phenotypes.<sup><xref ref-type="bibr" rid="bibr40-2470547020924844">40</xref>,<xref ref-type="bibr" rid="bibr41-2470547020924844">41</xref></sup> The results of GWAS are typically displayed as a Manhattan plot with base-pair positions ordered per chromosome on the <italic>x</italic>-axis and significance (–log<sub>10</sub>(association <italic>p</italic> value)) on the <italic>y</italic>-axis, creating a densely populated plot mimicking the Manhattan skyline.</p>
<p>A successful GWAS requires a well-considered phenotype. Three diagnostic classification systems for psychiatric disorders are used worldwide.<sup><xref ref-type="bibr" rid="bibr42-2470547020924844">42</xref></sup> The Diagnostic and Statistical Manual of Mental Disorders (DSM, currently the 5th edition) was developed by the American Psychiatric Association and is used primarily to guide clinical practice and mental health research. The International Classification of Diseases (ICD) was developed by the World Health Organization (WHO) and is used by clinicians for charting patient diagnosis of both physical and mental health conditions.<sup><xref ref-type="bibr" rid="bibr43-2470547020924844">43</xref><xref ref-type="bibr" rid="bibr44-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr45-2470547020924844">45</xref></sup> The application of each system varies widely throughout the world, where DSM is widely used in the United States in contrast to the predominance of ICD in Europe.<sup><xref ref-type="bibr" rid="bibr42-2470547020924844">42</xref></sup> While there is a high degree of overlap between these systems, there is clinical heterogeneity, for example, in classifying some psychiatric outcomes.<sup><xref ref-type="bibr" rid="bibr46-2470547020924844">46</xref>,<xref ref-type="bibr" rid="bibr47-2470547020924844">47</xref></sup> Phenotype heterogeneity may alter the sample allele distribution leading to (i) false negatives (i.e. true differences in allele frequency are masked) or (ii) false positives (i.e. allele frequency differences due to unbalanced phenotype distribution).<sup><xref ref-type="bibr" rid="bibr48-2470547020924844">48</xref></sup> The Research Domain Criteria (RDoC) paradigm compliments DSM and ICD classification systems by assessing clinical phenotypes hypothesized to more closely map onto underlying biological systems (e.g. neuroimaging data<sup><xref ref-type="bibr" rid="bibr49-2470547020924844">49</xref></sup> and brain circuit activity<sup><xref ref-type="bibr" rid="bibr50-2470547020924844">50</xref></sup>). RDoC-based approaches offer an alternative to heterogeneous diagnostic systems, by permitting assessment of negative and positive valence, cognitive systems, sensorimotor systems, social processing systems, and/or arousal and regulatory systems across persons affected by different disorders, as well as healthy comparison subjects. Psychiatric disorders are often diagnosed based on a heterogeneous combination of symptom counts (i.e. an individual endorses a subset of symptoms but may not meet all criteria) as well as meeting full diagnostic criteria. These features also may be assessed for lifetime prevalence or, for example, last month prevalence. Note that herein we summarize findings from large studies of psychiatric disorders assessed with different instruments and considering different diagnostic criteria.</p>
<p>Large-scale GWAS have been used to understand many aspects of psychiatric disorders beyond risk locus detection. Analysis of GWAS after locus discovery is often termed “post-GWAS” analysis. Post-GWAS analyses are commonly used to follow-up risk locus discovery with additional sophisticated interpretation of GWAS signals. Some of these analyses are briefly described here. First, observed-scale heritability based on GWAS data (SNP-<italic>h</italic><sup>2</sup>) reflects the contribution of common genetic information (rather than environmental or rare genetic factors) to the trait (<xref ref-type="fig" rid="fig1-2470547020924844">Figure 1</xref>). This phenotype attribute may be conflated in case-control study designs by enrichment of cases relative to the general population prevalence. SNP-<italic>h</italic><sup>2</sup> also may be biased by residual population stratification from (i) higher than expected relatedness among samples or (ii) phenotype definition heterogeneity. It is understood that different functional classes of the genome disproportionately contribute to the SNP-<italic>h</italic><sup>2</sup>. SNP-<italic>h</italic><sup>2</sup> estimates may then be partitioned to identify enrichment or depletion of certain functional classes of the genome such as enhancers, promoters, epigenetically regulated regions, and evolutionarily conserved regions. Another frequently-used post-GWAS method is genetic correlation whereby the per-SNP effects on one trait are regressed against the per-SNP effects of a second trait. The genetic liability for two traits may be positively, negatively, or not correlated. More sophisticated analytic tools also shed light on, or take advantage of, the polygenicity of psychiatric disorders, including (i) polygenic risk scoring (PRS, i.e. regressing weighted sum of per-SNP effects from one trait against another), (ii) Mendelian randomization (i.e. evaluating causality between phenotypes using genetic information as instrumental variables), (iii) functional annotation, fine-mapping, and co-localization to untangle polygenicity and prioritize casual risk loci, and (iv) structural equation modeling (i.e. identifying latent factors connecting phenotypes based on their genetic similarities).</p>
<fig id="fig1-2470547020924844" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Test statistics from large-scale GWAS of psychiatric disorders (PMIDs provided) shed light on heritability and polygenicity. The orange bars represent the LDSC (linkage disequilibrium score regression) intercept, which indicates the presence of potential biases in the association analysis. The purple triangles represent the genomic inflection factor, which reflects the polygenicity of the trait when no inflation is present. The full black circles represent the SNP-Heritability. Where these statistics were not included in the associated manuscripts, they were calculated with LDSC using the 1000 Genomes Project European LD reference panel. For case-control phenotypes, SNP-<italic>h</italic><sup>2</sup> is plotted on the liability scale.</p>
<p>SNP: single nucleotide polymorphism.</p>
</caption>
<graphic xlink:href="10.1177_2470547020924844-fig1"></graphic>
</fig>
</sec>
<sec id="sec3-2470547020924844">
<title>Schizophrenia</title>
<p>Schizophrenia (SCZ) is a severe psychiatric disorder affecting 1% of the worldwide population.<sup><xref ref-type="bibr" rid="bibr51-2470547020924844">51</xref></sup> Due to the high morbidity and mortality, it is also known as the “cancer of mental illness.”<sup><xref ref-type="bibr" rid="bibr52-2470547020924844">52</xref></sup> SCZ is diagnosed based on “positive” and “negative” symptoms. The former include hallucinations and delusions, while the latter involves avolition and withdrawal.<sup><xref ref-type="bibr" rid="bibr53-2470547020924844">53</xref>,<xref ref-type="bibr" rid="bibr54-2470547020924844">54</xref></sup> Additionally, SCZ cases often present with cognitive dysfunction and deficits in executive function.<sup><xref ref-type="bibr" rid="bibr55-2470547020924844">55</xref></sup> Twin- and family-based studies demonstrated that individuals related to SCZ cases have an increased lifetime disease risk, ranging from 50% for monozygotic twins to 2% for first cousins.<sup><xref ref-type="bibr" rid="bibr56-2470547020924844">56</xref></sup> Genome-wide studies based on high-throughput technologies have revolutionized our understanding of the genetic predisposition to SCZ. In 2014, the Psychiatric Genomics Consortium (PGC) conducted a GWAS in 36,989 SCZ cases and 113,075 controls,<sup><xref ref-type="bibr" rid="bibr18-2470547020924844">18</xref></sup> identifying 128 independent associations spanning 108 loci and proving that SCZ architecture is highly polygenic. In an updated PGC analysis including ∼60,000 SCZ cases,<sup><xref ref-type="bibr" rid="bibr57-2470547020924844">57</xref></sup> more than 250 GWS risk alleles have been identified, and an SCZ PRS showed that case-control group means differ by over 2/3 of a standard deviation (0.686; <italic>p</italic> = 1.1 × 10<sup>–254</sup>). Simulations of different degrees of polygenicity across complex traits showed that SCZ could be affected at least 20,000 causal loci.<sup><xref ref-type="bibr" rid="bibr58-2470547020924844">58</xref></sup> Among the SCZ-associated loci, the strongest association was observed in the major histocompatibility complex region.<sup><xref ref-type="bibr" rid="bibr59-2470547020924844">59</xref></sup> This appears to be due to structurally diverse alleles of the complement component 4 (C4) genes that lead to a greater expression of C4A in SCZ cases.<sup><xref ref-type="bibr" rid="bibr60-2470547020924844">60</xref></sup> Human C4 protein is localized to neuronal synapses, dendrites, and axons, and, in animal models, C4 appears to mediate synapse elimination during postnatal development.<sup><xref ref-type="bibr" rid="bibr60-2470547020924844">60</xref></sup> Although these previous findings support the role of increased synapse pruning in SCZ pathogenesis, a subsequent study in human postmortem brains showed that only the smallest dendritic spines are lost in deep layer 3 primary auditory cortex of SCZ, while larger dendritic spines are retained.<sup><xref ref-type="bibr" rid="bibr61-2470547020924844">61</xref></sup> While mechanistic studies are essential for understanding how genetic associations contribute to disease, genome-wide studies using polygenic instruments can shed light on genetic heterogeneity in relation to phenotypic heterogeneity across SCZ cases. Comparing SCZ and bipolar disorder (BD), it was possible to identify shared risk loci, as well as loci associated that distinguish the two disorders, and to characterize polygenic composition of multiple underlying symptom dimensions.<sup><xref ref-type="bibr" rid="bibr16-2470547020924844">16</xref></sup> Another SCZ characteristic is the negative association with cognitive ability and educational attainment.<sup><xref ref-type="bibr" rid="bibr62-2470547020924844">62</xref></sup> Genome-wide analyses showed that there is a positive genetic correlation between the liabilities to SCZ and educational attainment.<sup><xref ref-type="bibr" rid="bibr63-2470547020924844">63</xref></sup> This apparently “paradoxical” result is not due to possible confounders (e.g. LD or assortative mating) but suggests the presence of two potential SCZ subphenotypes: one resembling high intelligence and BD, while the other is a cognitive disorder that is independent of BD.<sup><xref ref-type="bibr" rid="bibr64-2470547020924844">64</xref></sup></p>
</sec>
<sec id="sec4-2470547020924844">
<title>Bipolar Disorder</title>
<p>BD is characterized by frequent mood swings between depressive and manic phases. The lifetime prevalence of BD is approximately 2.4% worldwide with twin-<italic>h</italic><sup>2</sup> of 80%.<sup><xref ref-type="bibr" rid="bibr65-2470547020924844">65</xref></sup> GWAS of BD have suggested a highly polygenic architecture so far comprising of 30 distinct loci associated with BD susceptibility.<sup><xref ref-type="bibr" rid="bibr66-2470547020924844">66</xref></sup> The most replicated risk genes are ankyrin 3 (<italic>ANK3</italic>) and calcium voltage-gated channel subunit alpha1 C (<italic>CACNA1C</italic>). Variants of these genes have been associated with white matter and total brain volume, thus implicating brain size as an intermediate phenotype. BD exists in two well-documented clinical subtypes: BD-I and BD-II.<sup><xref ref-type="bibr" rid="bibr66-2470547020924844">66</xref>,<xref ref-type="bibr" rid="bibr67-2470547020924844">67</xref></sup> BD-I is distinguished from BD-II by extreme manic episodes experienced by those affected.<sup><xref ref-type="bibr" rid="bibr68-2470547020924844">68</xref>,<xref ref-type="bibr" rid="bibr69-2470547020924844">69</xref></sup> The SNP-<italic>h</italic><sup>2</sup> of BD-I and BD-II have been estimated at 35% and 25%, respectively, with a 78% genetic overlap.<sup><xref ref-type="bibr" rid="bibr70-2470547020924844">70</xref></sup> This genetic overlap suggests many shared biological mechanisms contributing to each BD subtype but also suggests specific characteristics of the biological underpinnings of BD subtypes. For example, there was significantly greater relationship between (i) SCZ PRS and BD-I relative to BD-II and (ii) major depressive disorder (MDD) PRS and BD-II relative to BD-I.<sup><xref ref-type="bibr" rid="bibr66-2470547020924844">66</xref>,<xref ref-type="bibr" rid="bibr67-2470547020924844">67</xref>,<xref ref-type="bibr" rid="bibr70-2470547020924844">70</xref><xref ref-type="bibr" rid="bibr71-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr72-2470547020924844">72</xref></sup> To date, the molecular mechanisms underlying these differences have yet to be robustly identified, but it is clear that studying BD as a single disorder may inflate heterogeneity and reduce power to detect the polygenic burden responsible for BD subtypes.</p>
</sec>
<sec id="sec5-2470547020924844">
<title>Attention Deficit Hyperactivity Disorder</title>
<p>Attention-deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders affecting youths in the United States.<sup><xref ref-type="bibr" rid="bibr73-2470547020924844">73</xref></sup> ADHD is characterized by inability to focus, impulsivity, age-inappropriate hyperactivity, and increased rates of antisocial, anxiety, mood, and substance use disorders (SUDs). The lifetime ADHD prevalence ranges from 2% to 12%<sup><xref ref-type="bibr" rid="bibr74-2470547020924844">74</xref></sup> with twin-<italic>h</italic><sup>2</sup> estimates between 74% and 80%.<sup><xref ref-type="bibr" rid="bibr75-2470547020924844">75</xref></sup> A GWAS of 20,183 ADHD cases and 35,191 controls identified 12 GWS risk loci for ADHD and significant differences in SNP-<italic>h</italic><sup>2</sup> and risk locus detection between sexes.<sup><xref ref-type="bibr" rid="bibr19-2470547020924844">19</xref>,<xref ref-type="bibr" rid="bibr76-2470547020924844">76</xref><xref ref-type="bibr" rid="bibr77-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr78-2470547020924844">78</xref></sup> Males are two to seven times more likely to be diagnosed with ADHD than females and largely dominate the samples included in current GWAS.<sup><xref ref-type="bibr" rid="bibr78-2470547020924844">78</xref>,<xref ref-type="bibr" rid="bibr79-2470547020924844">79</xref></sup> Several hypotheses have been proposed for this sex difference. First is the scenario that female ADHD is associated with a different set of variants as compared with male ADHD.<sup><xref ref-type="bibr" rid="bibr80-2470547020924844">80</xref>,<xref ref-type="bibr" rid="bibr81-2470547020924844">81</xref></sup> Another hypothesis is that females are more resilient to developing ADHD and require a higher genetic burden to present relevant diagnostic symptoms.<sup><xref ref-type="bibr" rid="bibr82-2470547020924844">82</xref>,<xref ref-type="bibr" rid="bibr83-2470547020924844">83</xref></sup> Though ADHD in males and females are highly genetically and phenotypically correlated,<sup><xref ref-type="bibr" rid="bibr78-2470547020924844">78</xref>,<xref ref-type="bibr" rid="bibr82-2470547020924844">82</xref></sup> GWAS are only beginning to elucidate the differences in genetic liability to ADHD across sexes. So far, there is minimal evidence that polygenic risk for ADHD contributes to, or shares underlying biology with, different co-occurring conditions or behaviors unique to each sex.<sup><xref ref-type="bibr" rid="bibr84-2470547020924844">84</xref></sup> To date, there have been no GWS findings for ADHD in females though this may be attributed to decreased sample size and lower population prevalence. ADHD PRS has shown positive associations with educational and cognitive outcomes,<sup><xref ref-type="bibr" rid="bibr85-2470547020924844">85</xref></sup> body mass index,<sup><xref ref-type="bibr" rid="bibr84-2470547020924844">84</xref></sup> neuroticism,<sup><xref ref-type="bibr" rid="bibr86-2470547020924844">86</xref></sup> externalizing behaviors (e.g. smoking, aggression, impulsivity, risk-taking),<sup><xref ref-type="bibr" rid="bibr82-2470547020924844">82</xref>,<xref ref-type="bibr" rid="bibr84-2470547020924844">84</xref>,<xref ref-type="bibr" rid="bibr85-2470547020924844">85</xref>,<xref ref-type="bibr" rid="bibr87-2470547020924844">87</xref></sup> and interpersonal communication behaviors.<sup><xref ref-type="bibr" rid="bibr88-2470547020924844">88</xref></sup> In addition to sex differences, ADHD is one of the most heterogeneously diagnosed psychiatric disorders with over 116,200 diagnostic combinations according to DSM-IV and DSM-5 criterion counts. Additionally, not all criteria are required to make an ADHD diagnosis such that two individuals with ADHD may not share any diagnostic criteria resulting in a level of diagnostic heterogeneity that may confound risk locus effects in genetic studies of ADHD.<sup><xref ref-type="bibr" rid="bibr89-2470547020924844">89</xref></sup> For example, the commonly implicated <italic>DAT1</italic> underlying ADHD psychopathology has only robustly been implicated in ADHD cases without conduct-related diagnostic criteria.<sup><xref ref-type="bibr" rid="bibr75-2470547020924844">75</xref>,<xref ref-type="bibr" rid="bibr90-2470547020924844">90</xref></sup></p>
</sec>
<sec id="sec6-2470547020924844">
<title>Autism Spectrum Disorder</title>
<p>Autism spectrum disorder (ASD) is the term used to describe a group of pervasive neurodevelopmental disorders characterized by impairment in social and communication skills often accompanied by repetitive and restrictive behaviors.<sup><xref ref-type="bibr" rid="bibr23-2470547020924844">23</xref></sup> Clinical manifestation of ASD is highly heterogeneous with the majority of ASD individuals receiving a diagnosis during early childhood and adolescence.<sup><xref ref-type="bibr" rid="bibr91-2470547020924844">91</xref><xref ref-type="bibr" rid="bibr92-2470547020924844"></xref><xref ref-type="bibr" rid="bibr93-2470547020924844"></xref><xref ref-type="bibr" rid="bibr94-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr95-2470547020924844">95</xref></sup> Heterogeneity in ASD may manifest as intellectual capabilities ranging from severe disability to high intelligence quotients<sup><xref ref-type="bibr" rid="bibr96-2470547020924844">96</xref></sup> or the type of social cognition impaired (i.e. person-perceptive <italic>versus</italic> people-perceptive social skills).<sup><xref ref-type="bibr" rid="bibr97-2470547020924844">97</xref>,<xref ref-type="bibr" rid="bibr98-2470547020924844">98</xref></sup> Clinically, specific ASD diagnoses tend to be defined based on the degree of intellectual ability in the affected. Asperger’s syndrome, for example, represents some of the least severe cognitive impairments along the autism spectrum.<sup><xref ref-type="bibr" rid="bibr99-2470547020924844">99</xref>,<xref ref-type="bibr" rid="bibr100-2470547020924844">100</xref></sup> Because ASD manifests as a spectrum of phenotypes, grouping individuals into ASD cases <italic>versus</italic> controls may introduce heterogeneity even though cases cluster together on the primary phenotype level. It has been demonstrated that reducing this spectrum phenotype heterogeneity only modestly improves genetic homogeneity in contemporary studies with large ASD sample sizes.<sup><xref ref-type="bibr" rid="bibr96-2470547020924844">96</xref></sup> ASD affects 1% to 1.5% of the population, and males are diagnosed more often than females.<sup><xref ref-type="bibr" rid="bibr101-2470547020924844">101</xref></sup> Similar to ADHD, the hypothesis of a female protective effect exists for ASD whereby females may require a greater genetic burden to develop symptoms.<sup><xref ref-type="bibr" rid="bibr101-2470547020924844">101</xref></sup> There is evidence that testosterone levels of males relative to females may contribute to increased vulnerability to etiological factors in ASD cases<sup><xref ref-type="bibr" rid="bibr102-2470547020924844">102</xref>,<xref ref-type="bibr" rid="bibr103-2470547020924844">103</xref></sup> and putatively defines mechanistic factors inducing heterogeneity detectable by large-scale genetic studies. These sex differences have recently been implicated in investigation strategies of empathizing-systemizing and automatizing-systemizing theories of ASD heterogeneity.<sup><xref ref-type="bibr" rid="bibr97-2470547020924844">97</xref>,<xref ref-type="bibr" rid="bibr98-2470547020924844">98</xref>,<xref ref-type="bibr" rid="bibr104-2470547020924844">104</xref><xref ref-type="bibr" rid="bibr105-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr106-2470547020924844">106</xref></sup> The polygenic risk for ASD has been associated with cognitive ability,<sup><xref ref-type="bibr" rid="bibr107-2470547020924844">107</xref></sup> various changes in DNA methylation at birth,<sup><xref ref-type="bibr" rid="bibr108-2470547020924844">108</xref></sup> and gray matter volume in healthy and psychiatric patients.<sup><xref ref-type="bibr" rid="bibr109-2470547020924844">109</xref></sup> Studies of the relationship between genetic risk for ASD and other human health and disease phenotypes have revealed interesting findings. First, ASD genetic risk indeed predicts ASD severity; however, ASD PRS do not cleanly stratify individuals into more clinically severe ASD symptom criteria.<sup><xref ref-type="bibr" rid="bibr107-2470547020924844">107</xref>,<xref ref-type="bibr" rid="bibr110-2470547020924844">110</xref></sup> This observation suggests that though phenotypic ASD subtypes exist, they may not appropriately stratify ASD for genetic studies.<sup><xref ref-type="bibr" rid="bibr96-2470547020924844">96</xref></sup> Second, the genetic risk for ASD in ASD unaffected individuals (i.e. unaffected individuals carrying ASD) associates with features of healthy neurodevelopment.<sup><xref ref-type="bibr" rid="bibr98-2470547020924844">98</xref>,<xref ref-type="bibr" rid="bibr106-2470547020924844">106</xref></sup></p>
</sec>
<sec id="sec7-2470547020924844">
<title>Posttraumatic Stress Disorder</title>
<p>Posttraumatic stress disorder (PTSD) affects individuals who have experienced, witnessed, or been confronted with an event involving actual or threatened danger. This required environmental component of PTSD makes it unique among DSM-5 disorders without such required etiologies. Diversity among traumatic experience adds substantial heterogeneity to PTSD cases, and this diversity can be detected with GWAS.<sup><xref ref-type="bibr" rid="bibr27-2470547020924844">27</xref>,<xref ref-type="bibr" rid="bibr30-2470547020924844">30</xref></sup> Given the abundance of PTSD in veteran populations, exposure to combat-related experiences has garnered much attention. Two large studies of PTSD estimated SNP-<italic>h</italic><sup>2</sup> of 2% to 5% in the PGC international meta-analysis and 6.4% to 10.1% in the Million Veteran Program (MVP).<sup><xref ref-type="bibr" rid="bibr30-2470547020924844">30</xref></sup> These cohorts represent different trauma exposures with MVP comprised mostly of males exposed to military combat and PGC comprised of international sex-balanced PTSD cases exposed primarily to civilian traumas. Traumatic events vary by sex, demography, and socioeconomic status. Males have higher rates of overall trauma exposure, yet females are more likely to develop PTSD following similar trauma, resulting in approximately doubled lifetime PTSD prevalence in U.S. females (8%) relative to males (4.1%).<sup><xref ref-type="bibr" rid="bibr111-2470547020924844">111</xref>,<xref ref-type="bibr" rid="bibr112-2470547020924844">112</xref></sup> Furthermore, sexual trauma is more prevalent among females, and males are more likely to experience nonsexual assaults, death/injury, and military combat. Specific traumas also appear to convey different magnitudes of risk for PTSD.<sup><xref ref-type="bibr" rid="bibr113-2470547020924844">113</xref></sup> Sex differences are reflected in sex-stratified GWAS where the SNP-<italic>h</italic><sup><xref ref-type="bibr" rid="bibr2-2470547020924844">2</xref></sup> of PTSD in males was no different from zero regardless of ancestry and the SNP-<italic>h</italic><sup><xref ref-type="bibr" rid="bibr2-2470547020924844">2</xref></sup> of PTSD in females was 8% to 18% with African ancestry individuals demonstrating the highest SNP-<italic>h</italic><sup>2</sup> estimates.<sup><xref ref-type="bibr" rid="bibr27-2470547020924844">27</xref>,<xref ref-type="bibr" rid="bibr114-2470547020924844">114</xref></sup> Additional heterogeneity of PTSD can be seen among the responses to trauma evaluated for PTSD diagnosis.<sup><xref ref-type="bibr" rid="bibr22-2470547020924844">22</xref>,<xref ref-type="bibr" rid="bibr30-2470547020924844">30</xref></sup> Including the PTSD symptom criteria of reexperiencing, avoidance, negative emotional symptoms, and hyperarousal, there are 636,120 possible combinations by which a person may be diagnosed with PTSD.<sup><xref ref-type="bibr" rid="bibr115-2470547020924844">115</xref></sup> Several loci (localizing near genes <italic>MAD1L1</italic>, <italic>TCF4</italic>, and <italic>TSNARE1</italic>) have been implicated across symptoms, lending support for these loci as putative targets for PTSD treatment. Lastly, there is considerable heterogeneity in the longitudinal course of PTSD, with distinct trajectories of symptom onset, severity, and remission that may be in part related to trauma context, sex, access to care, and other unmeasured influences.<sup><xref ref-type="bibr" rid="bibr116-2470547020924844">116</xref>,<xref ref-type="bibr" rid="bibr117-2470547020924844">117</xref></sup> Future work in PTSD genetics will surely begin addressing how differences in genetic risk also influence PTSD trajectory and prognosis.</p>
</sec>
<sec id="sec8-2470547020924844">
<title>Major Depressive Disorder</title>
<p>MDD is the unceasing depressive or low mood lasting for more than two weeks accompanied by disturbances in weight, circadian rhythms, elevated negative emotions, and self-debilitating thoughts. The lifetime prevalence of MDD in the United States is approximately 20.6%,<sup><xref ref-type="bibr" rid="bibr118-2470547020924844">118</xref></sup> and twin-<italic>h</italic><sup>2</sup> is estimated between 30% and 40%.<sup><xref ref-type="bibr" rid="bibr119-2470547020924844">119</xref></sup> MDD is associated with socioeconomic burden and all-cause mortality and is thus a leading cause of disease burden worldwide.<sup><xref ref-type="bibr" rid="bibr120-2470547020924844">120</xref></sup> Phenotypic heterogeneity of MDD is primarily driven by sex differences; the lifetime prevalence of MDD in females is 26.1% and in males is 14.7%.<sup><xref ref-type="bibr" rid="bibr118-2470547020924844">118</xref></sup> To date, GWAS have identified many loci conferring risk for MDD, the largest of which (<italic>N </italic>=<italic> </italic>807,553 individuals) detected 102 MDD risk loci.<sup><xref ref-type="bibr" rid="bibr24-2470547020924844">24</xref>,<xref ref-type="bibr" rid="bibr32-2470547020924844">32</xref>,<xref ref-type="bibr" rid="bibr121-2470547020924844">121</xref><xref ref-type="bibr" rid="bibr122-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr123-2470547020924844">123</xref></sup> Though effective sample sizes continue to increase, SNP-<italic>h</italic><sup>2</sup> estimates converge between 8.7% and 8.9%.<sup><xref ref-type="bibr" rid="bibr24-2470547020924844">24</xref></sup> Heterogeneity in MDD may be evident by the presence of five DSM-IV diagnostic criteria and lower SNP-<italic>h</italic><sup>2</sup> estimates in males <italic>versus</italic> females.<sup><xref ref-type="bibr" rid="bibr124-2470547020924844">124</xref></sup> Furthermore, many of the single-item criteria for an MDD diagnosis (e.g. “nerves, anxiety, tension or depression,” and “self-reported depressive symptoms with associated impairment” items in the UK biobank) overlap with multi-item diagnostic instruments for other disorders such as BD and SCZ.<sup><xref ref-type="bibr" rid="bibr24-2470547020924844">24</xref>,<xref ref-type="bibr" rid="bibr121-2470547020924844">121</xref>,<xref ref-type="bibr" rid="bibr125-2470547020924844">125</xref></sup> These shared diagnostic criteria may reduce accuracy of PRS in stratifying MDD individuals and introducing heterogeneous genetic associations. It is important to note that MDD, like other psychiatric disorders, exists as a spectrum rather than clear case-control distinction, and the reduction of MDD into such a binary classification system may introduce heterogeneity among case and control categories.</p>
</sec>
<sec id="sec9-2470547020924844">
<title>Obsessive-Compulsive Disorder</title>
<p>Obsessive-compulsive disorder (OCD) is characterized by recurrent, intrusive, or unwanted thoughts, images, or impulses that provoke anxiety and actions to ameliorate that anxiety. OCD cases display concerns about contamination, responsibility for harm or injury, unacceptable thoughts that are often sexual and/or religious in nature, and symmetry, completeness, and the need for things to be “just right.” Compulsive behaviors to neutralize anxiety include excessive cleaning/hygiene, repeated checking, or other ritualized thoughts and behaviors. The lifetime prevalence of OCD is 1% to 3%,<sup><xref ref-type="bibr" rid="bibr126-2470547020924844">126</xref>,<xref ref-type="bibr" rid="bibr127-2470547020924844">127</xref></sup> and twin-<italic>h</italic><sup>2</sup> is estimated to be 48%.<sup><xref ref-type="bibr" rid="bibr128-2470547020924844">128</xref></sup> To date, OCD GWAS have not detected any GWS risk loci, but genetic data estimate SNP-<italic>h</italic><sup>2</sup> at 28%.<sup><xref ref-type="bibr" rid="bibr129-2470547020924844">129</xref></sup> There are notable sex differences observed in clinical presentations of OCD, with males comprising roughly two thirds of childhood-onset cases and reporting a higher incidence of obsessions related to religious/sexual thoughts and symmetry themes.<sup><xref ref-type="bibr" rid="bibr127-2470547020924844">127</xref>,<xref ref-type="bibr" rid="bibr130-2470547020924844">130</xref></sup> Females are more likely to present with late-onset OCD and report higher rates of precipitating events (e.g. pregnancy and childbirth), exacerbation of symptoms with hormonal events, and higher rates of comorbid eating disorder.<sup><xref ref-type="bibr" rid="bibr127-2470547020924844">127</xref>,<xref ref-type="bibr" rid="bibr130-2470547020924844">130</xref></sup> Obsessive themes among females with OCD tend to center around hygiene.<sup><xref ref-type="bibr" rid="bibr127-2470547020924844">127</xref></sup> Large-scale GWAS of OCD in sex-stratified cohorts failed to detect significant SNP-<italic>h</italic><sup>2</sup> in males but estimate significant SNP-<italic>h</italic><sup>2</sup> in females (30%). Sex-stratified OCD GWAS are underpowered to formally test the genetic correlation between them; however, per-SNP effect sizes tend to positively associate. One study suggested that SNP-<italic>h</italic><sup>2</sup> may vary across different age groups with greater SNP-<italic>h</italic><sup>2</sup> estimates in OCD of younger individuals (<italic>h</italic><sup>2</sup>=0.43) versus older individuals (<italic>h</italic><sup>2</sup> not significant).<sup><xref ref-type="bibr" rid="bibr131-2470547020924844">131</xref></sup> OCD has received considerable attention due to its relationship with other psychiatric disorders. In a familial co-aggregation study, first-degree relatives of OCD patients had more than double the risk for BD (relative risk (RR) confidence interval (CI) = 2.68–3.04), MDD (RR CI = 2.58–2.67), ASD (RR CI = 2.10–2.71), ADHD (RR CI = 2.07–2.32), and SCZ (RR CI = 1.86–2.09).<sup><xref ref-type="bibr" rid="bibr132-2470547020924844">132</xref></sup> Exploring how OCD relates to these other psychiatric disorder revealed overlapping exomes and polygenic risk between OCD and SCZ and identified <italic>DMN3</italic> as one suggestive link between the two disorders.<sup><xref ref-type="bibr" rid="bibr133-2470547020924844">133</xref></sup></p>
</sec>
<sec id="sec10-2470547020924844">
<title>Tourette’s Syndrome and Chronic Tic Disorder</title>
<p>Tourette’s syndrome (TS) is typically diagnosed before 18 years of age and requires two or more motor and at least one phonic tic lasting more than one year.<sup><xref ref-type="bibr" rid="bibr134-2470547020924844">134</xref></sup> The related diagnosis, chronic tic disorder (CTD), requires the presence of two or more of either motor or phonic tics, but not both. TS has a prevalence of 0.3% to 0.8% and occurs more frequently in males, at a ratio of approximately 3.5:1,<sup><xref ref-type="bibr" rid="bibr135-2470547020924844">135</xref></sup> with similar prevalence reported for CTD.<sup><xref ref-type="bibr" rid="bibr136-2470547020924844">136</xref>,<xref ref-type="bibr" rid="bibr137-2470547020924844">137</xref></sup> Though males tend to be diagnosed more often than females, females experience greater day-to-day burden of more severe tics.<sup><xref ref-type="bibr" rid="bibr138-2470547020924844">138</xref><xref ref-type="bibr" rid="bibr139-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr140-2470547020924844">140</xref></sup> The largest GWAS of TS (<italic>N </italic>=<italic> </italic>14,307) identified a single GWS variant and 39 suggestive associations.<sup><xref ref-type="bibr" rid="bibr33-2470547020924844">33</xref></sup> Estimates of TS SNP-<italic>h</italic><sup>2</sup> range from 21% to 58%,<sup><xref ref-type="bibr" rid="bibr33-2470547020924844">33</xref>,<xref ref-type="bibr" rid="bibr131-2470547020924844">131</xref></sup> with twin-<italic>h</italic><sup>2</sup> estimates up to 60%.<sup><xref ref-type="bibr" rid="bibr131-2470547020924844">131</xref></sup> TS PRS were predictive of clinical status in independent samples, with probands from multiplex families showing higher loading than those from simplex families.<sup><xref ref-type="bibr" rid="bibr33-2470547020924844">33</xref>,<xref ref-type="bibr" rid="bibr141-2470547020924844">141</xref></sup> Individuals with CTD have elevated TS PRS relative to controls. Childhood neurodevelopmental disorders (e.g. ADHD, ASD, OCD, and TS/CTD) share elevated rates of comorbidity as well as shared subphenotypes (e.g. executive functioning, impulse control, intrusive thoughts, repetitive behaviors, and rigid adherence to routines), which pose challenges for both clinical subphenotyping and for understanding genetic effects. TS PRS have been associated with (i) the presence, but not chronicity of tics and (ii) the severity of symptoms associated with comorbid conditions.<sup><xref ref-type="bibr" rid="bibr142-2470547020924844">142</xref></sup> Much of the heterogeneity associated with TS and CTD stems from the relationship between TS/CTD and OCD and ADHD. Two TS subphenotypes have been detected, the symmetry subphenotype and disinhibition subphenotype, which have distinct genetic architectures not fully understood due to strict adherence to DSM-based diagnoses.<sup><xref ref-type="bibr" rid="bibr143-2470547020924844">143</xref></sup> The symmetry subphenotype was positively predicted by TS (but not OCD or ADHD) PRS, while the disinhibition subphenotype was predicted by OCD (but no other) PRS. In a cross-trait gene-based study of OCD and TS, <italic>CADM2</italic>, <italic>LY6G6F</italic>, <italic>MEGT1</italic>, and <italic>APOM</italic> were identified as GWS loci but were not detected in other pairwise neurodevelopmental disorder gene-based analyses<sup><xref ref-type="bibr" rid="bibr142-2470547020924844">142</xref></sup> To disentangle and specify genetic relationships among these disorders, future studies may benefit from (i) the incorporation of shared intermediate phenotypes (ii) <italic>post hoc</italic> conditioning of analyses to remove shared or nonspecific effects, and (iii) investigating molecular mechanism involving identified gene targets shared and differentially expressed between TS and other psychiatric disorders (e.g. OCD).<sup><xref ref-type="bibr" rid="bibr143-2470547020924844">143</xref></sup></p>
</sec>
<sec id="sec11-2470547020924844">
<title>Anxiety Disorders</title>
<p>Anxiety disorders in DSM-5 include separation anxiety, selective mutism, specific phobias, panic disorder, agoraphobia, and generalized anxiety disorder (GAD). The lifetime prevalence of anxiety is estimated at 31%.<sup><xref ref-type="bibr" rid="bibr144-2470547020924844">144</xref>,<xref ref-type="bibr" rid="bibr145-2470547020924844">145</xref></sup> Twin studies suggest anxiety disorder twin-<italic>h</italic><sup>2</sup> of 42%.<sup><xref ref-type="bibr" rid="bibr146-2470547020924844">146</xref></sup> Anxiety disorders are quite heterogeneous, and many subtypes are ubiquitously more prevalent in females.<sup><xref ref-type="bibr" rid="bibr147-2470547020924844">147</xref></sup> GAD is perhaps the most thoroughly investigated by large-scale GWAS. GAD is defined as the presence of excessive anxiety and worry about a variety of topics, events, or activities, typically lasting more than six months. The excessive worry associated with GAD is often to the point where the affected cannot control themselves. Physical symptomology often varies between cases and may include edginess, impaired concentration, empty mindedness, irritability, muscle aches, and sleeplessness.<sup><xref ref-type="bibr" rid="bibr148-2470547020924844">148</xref><xref ref-type="bibr" rid="bibr149-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr150-2470547020924844">150</xref></sup> Recent GWAS of GAD in &gt;200,000 U.S. military veterans identified risk loci shared between GAD and SCZ and BD.<sup><xref ref-type="bibr" rid="bibr25-2470547020924844">25</xref></sup> Collectively, the polygenic architecture of GAD-2 (a two-item GAD symptom criterion checklist) significantly overlapped with MDD, neuroticism, and PTSD.<sup><xref ref-type="bibr" rid="bibr25-2470547020924844">25</xref></sup> Though significant overlap exists between various measures of anxiety disorders (anxiety case-control,<sup><xref ref-type="bibr" rid="bibr151-2470547020924844">151</xref></sup> GAD-2,<sup><xref ref-type="bibr" rid="bibr25-2470547020924844">25</xref></sup> and GAD-7<sup>152</sup>), these overlaps are not perfect, suggesting that the distribution of anxiety symptoms in study cohorts may be readily detected in the associated genetic data. Anxiety disorders demonstrate substantial heterogeneity based on age of the ascertained cohort.<sup><xref ref-type="bibr" rid="bibr153-2470547020924844">153</xref>,<xref ref-type="bibr" rid="bibr154-2470547020924844">154</xref></sup> Two anxiety disorders, separation anxiety and selective mutism, were once thought to be exclusively childhood disorders, but it is now accepted that children and adults may receive these diagnoses. There also is evidence that environmental heterogeneity, such as childhood maltreatment, moderate polygenic risk in genetic studies of anxiety disorders.<sup><xref ref-type="bibr" rid="bibr155-2470547020924844">155</xref><xref ref-type="bibr" rid="bibr156-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr157-2470547020924844">157</xref></sup></p>
</sec>
<sec id="sec12-2470547020924844">
<title>Suicidality</title>
<p>Worldwide, more than 1 million people complete suicide every year making it the 10th leading cause of death in the United States (12.6 deaths per 100,000).<sup><xref ref-type="bibr" rid="bibr158-2470547020924844">158</xref></sup> Nonfatal suicidal behaviors also are a consistent emotional and economic burden. Suicidal ideation, plans, gestures, attempts, and completed suicides represent a continuum of suicidal behavior. There is one death by suicide for every 25 attempts,<sup><xref ref-type="bibr" rid="bibr159-2470547020924844">159</xref></sup> and some of attempts are severe enough to require medical attention and may have long-lasting sequelae. Having a psychiatric disorder is a major risk factor for suicidal behaviors and individuals affected by a mental illness may represent at least 90% of the people who have died by suicide.<sup><xref ref-type="bibr" rid="bibr160-2470547020924844">160</xref></sup> However, most people with mental disorders do not die by suicide, and the risk of suicide is 5% to 8% for several mental disorders.<sup><xref ref-type="bibr" rid="bibr161-2470547020924844">161</xref></sup> According to the stress-diathesis model, the risk for suicidal acts is determined a stressor (such as psychiatric illness) and a diathesis, such as a tendency to experience more suicidal ideation and be more likely to act on suicidal feelings.<sup><xref ref-type="bibr" rid="bibr162-2470547020924844">162</xref></sup> Twin, family, and adoption studies identified a 30% to 50% <italic>h</italic><sup>2</sup> which appears to be partially independent from psychiatric disorders.<sup><xref ref-type="bibr" rid="bibr163-2470547020924844">163</xref></sup> GWAS have just started to investigate suicidal behaviors in relatively large cohorts.<sup><xref ref-type="bibr" rid="bibr67-2470547020924844">67</xref>,<xref ref-type="bibr" rid="bibr164-2470547020924844">164</xref><xref ref-type="bibr" rid="bibr165-2470547020924844"></xref><xref ref-type="bibr" rid="bibr166-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr167-2470547020924844">167</xref></sup> These analyses were conducted on cohorts with different characteristics including general population, military personnel, and individuals affected by psychiatric disorders. Although few risk loci were identified, a consistent genetic overlap has been observed between MDD and suicidal behaviors.<sup><xref ref-type="bibr" rid="bibr67-2470547020924844">67</xref>,<xref ref-type="bibr" rid="bibr164-2470547020924844">164</xref><xref ref-type="bibr" rid="bibr165-2470547020924844"></xref><xref ref-type="bibr" rid="bibr166-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr167-2470547020924844">167</xref></sup> A recent multivariate genome-wide interaction study detected that genetic risk for suicidal behaviors is partially moderated by multivariate gene interactions linking comorbid substance dependences with suicidal ideation.<sup><xref ref-type="bibr" rid="bibr168-2470547020924844">168</xref></sup> This suggests that the phenotypic heterogeneity among individuals experiencing suicidal behaviors increases the genetic complexity of these traits. Genome-wide approaches have the potential to disentangle the diverse characteristics observed among individuals experiencing suicidal feelings and committing a suicidal attempt. However, much more informative cohorts are needed to achieve a comprehensive understanding of the molecular basis of suicidal behaviors.</p>
</sec>
<sec id="sec13-2470547020924844">
<title>Feeding and Eating Disorders</title>
<p>Eating disorders are classified as abnormal eating episodes occurring intermittently or frequently and lasting for more than three months. DSM-IV recognized three primary diagnoses: anorexia nervosa (AN), bulimia nervosa (BN), and eating disorders not otherwise specified (called EDNOS; diagnosed by omission of symptom criteria for AN and BN). The prevalence rates of eating disorders are affected by socioeconomic status. Females experience higher prevalence than men, non-Hispanic populations of European descent tend to have higher prevalence than individuals of other ethnicities, and there is some evidence that family income may contribute to eating disorder prevalence.<sup><xref ref-type="bibr" rid="bibr169-2470547020924844">169</xref></sup> Psychiatric comorbidities are common among eating disorder cases, including MDD, anxiety, and OCD.<sup><xref ref-type="bibr" rid="bibr170-2470547020924844">170</xref></sup> The twin-<italic>h</italic><sup>2</sup> of eating disorders varies from 40% to 60%.<sup><xref ref-type="bibr" rid="bibr171-2470547020924844">171</xref></sup> The SNP-<italic>h</italic><sup>2</sup> of eating disorders (cases included AN and BN; <italic>N</italic>∼14,000) was 20% in early studies of this class of disorders.<sup><xref ref-type="bibr" rid="bibr172-2470547020924844">172</xref></sup></p>
<sec id="sec14-2470547020924844">
<title>Anorexia Nervosa</title>
<p>AN has a prevalence of 0.8% and is characterized by restricted eating, weight loss, difficulties maintaining an age- or height-appropriate body weight, and distorted body image. Genetic studies have mostly focused on AN likely due to the higher population prevalence compared to other eating disorders. The most recent and largest GWAS of 76,644 individuals detected eight risk loci using diagnostic criteria from DSM-III to DSM-5. The study reported SNP-<italic>h</italic><sup>2</sup> of approximately 11% and relatively high genomic lambda (1.22) but appropriate LD intercept which collectively provide evidence of high polygenicity. Partitioning the SNP-<italic>h</italic><sup>2</sup> for mouse model cell types identified spiny and pyramidal neurons of the hippocampus, which are responsible for feeding behavior and impetus. Additionally, reported genetic correlation of AN with psychiatric disorders and metabolic dysregulation parallels epidemiologically observed comorbidities.<sup><xref ref-type="bibr" rid="bibr31-2470547020924844">31</xref></sup></p>
</sec>
<sec id="sec15-2470547020924844">
<title>Bulimia Nervosa</title>
<p>BN is characterized by cycles of bingeing and caloric compensatory behaviors, such a vomiting, and its prevalence is 0.28%.<sup><xref ref-type="bibr" rid="bibr169-2470547020924844">169</xref></sup> While GWAS have provided much needed resolution of genetic liability to AN, the genetic liabilities of BN, and other eating disorders are less clear. Larger sample sizes will indeed be required to detect genetic correlations, SNP-<italic>h</italic><sup>2</sup>, and underlying biology associated with BN such that therapeutic and diagnostic interventions may be developed.<sup><xref ref-type="bibr" rid="bibr171-2470547020924844">171</xref></sup></p>
</sec>
</sec>
<sec id="sec16-2470547020924844">
<title>Substance Use Disorders</title>
<p>SUDs are characterized by uncontrolled desire for excessive substance intake and inability to reduce the frequency of consumption. According to the WHO, there are more than 180-million drug users worldwide.<sup><xref ref-type="bibr" rid="bibr173-2470547020924844">173</xref></sup> DSM-5 has expanded SUD definition to include gambling disorders and combines the concepts of substance abuse and dependence, though there is evidence of shared and specific genetic effects for these traits.<sup><xref ref-type="bibr" rid="bibr174-2470547020924844">174</xref></sup> Commonly studied substances include alcohol, stimulants (e.g. amphetamines and cocaine), tobacco, and opioids.<sup><xref ref-type="bibr" rid="bibr175-2470547020924844">175</xref></sup> Phenotypic heterogeneity in SUDs stems from various drug seeking patterns, environmental factors, pharmacokinetic and pharmacodynamic processes, and psychiatric comorbidities.<sup><xref ref-type="bibr" rid="bibr173-2470547020924844">173</xref></sup> The characterization of behavioral and psychiatric traits related to the use and abuse of addictive substances in large cohorts remain challenging due to several factors, such as the hypothesized differences in recreational versus prescription use and abuse and the societal stigma associated with use of certain substances over others. These barriers are being overcome through large consortium and biobank efforts, but studies of some substances (e.g. opioids and cocaine) remain underpowered to make robust conclusions about underlying biology.</p>
<sec id="sec17-2470547020924844">
<title>Alcohol</title>
<p>Individuals with alcohol use disorder (AUD) had high comorbidity with other psychiatric disorders, while alcohol consumption has a much lower genetic correlation with psychiatric disorders.<sup><xref ref-type="bibr" rid="bibr176-2470547020924844">176</xref></sup> AUD is measured by dependence on extreme alcohol consumption and has a twin-<italic>h</italic><sup>2</sup> of 50%.<sup><xref ref-type="bibr" rid="bibr177-2470547020924844">177</xref></sup> SNP-<italic>h</italic><sup>2</sup> for alcohol dependence averages around 10%. GWAS for alcohol dependence using DSM and alcohol consumption with the AUD Identification Test converge on variants in the alcohol metabolizing gene <italic>ADH1B</italic> and other genes (<italic>GCKR</italic>, <italic>SLC39A8</italic>, <italic>FTO</italic>, <italic>ADH4</italic>, <italic>SIX3</italic>, and <italic>DRD2</italic>) with shared biological functionality. Only half of the genes overlap between alcohol consumption and AUD suggesting distinct etiologies between consuming/using alcohol and being dependent on its effects.<sup><xref ref-type="bibr" rid="bibr178-2470547020924844">178</xref></sup></p>
</sec>
<sec id="sec18-2470547020924844">
<title>Nicotine</title>
<p>Smoking cigarettes, whose primary substance is nicotine, is a complex phenotype ranging from initiation, consistent pattern, dependence, termination, and reversion. The family-<italic>h</italic><sup>2</sup> for nicotine dependence is measured to be 75%.<sup><xref ref-type="bibr" rid="bibr179-2470547020924844">179</xref></sup> GWAS have consistently replicated a region on chromosome 15 consisting of <italic>CHRNA3</italic>, <italic>CHRNA4</italic>, and <italic>CHRNA5</italic> which explain 4% to 5% of the variance in smoking-related phenotypes. These results are analogous to other SUDs, drawing attention to biological heterogeneity varying with the severity of dependence.<sup><xref ref-type="bibr" rid="bibr174-2470547020924844">174</xref>,<xref ref-type="bibr" rid="bibr180-2470547020924844">180</xref>,<xref ref-type="bibr" rid="bibr181-2470547020924844">181</xref></sup></p>
</sec>
<sec id="sec19-2470547020924844">
<title>Opioids</title>
<p>Like AUDs, assessing differences between opioid use and dependence proves essential to understanding the polygenic architectures of these traits.<sup><xref ref-type="bibr" rid="bibr20-2470547020924844">20</xref></sup> A recent study comparing opioid-exposed versus unexposed controls detected SNP-<italic>h</italic><sup>2</sup> of 28%.<sup><xref ref-type="bibr" rid="bibr174-2470547020924844">174</xref></sup> A study conducted in 10,544 OUD cases and 72,163 opioid-exposed controls from the MVP cohort identified <italic>OPRM1</italic> Asn40Asp (rs1799971) as a significant risk locus, also showing genetic correlation with multiple substance use traits and psychiatric illnesses and possible causal effects on OUD risk from tobacco smoking, major depression, neuroticism, and cognitive performance.<sup><xref ref-type="bibr" rid="bibr34-2470547020924844">34</xref></sup></p>
</sec>
<sec id="sec20-2470547020924844">
<title>Cannabis</title>
<p>The family-wise <italic>h</italic><sup>2</sup> of cannabis use is 45%, and recent GWAS of 184,765 individuals reported SNP-<italic>h</italic><sup><xref ref-type="bibr" rid="bibr2-2470547020924844">2</xref></sup> of 11%. Genetic risk for cannabis use was positively genetically correlated with MDD and SCZ, risk-taking behavior, and neuroticism.<sup><xref ref-type="bibr" rid="bibr182-2470547020924844">182</xref></sup> Age at cannabis initiation also appears to be moderately heritable, and the significant association with <italic>ATP2C2</italic> is consistent with the role of calcium signaling mechanisms in the propensity to cannabis use.<sup><xref ref-type="bibr" rid="bibr183-2470547020924844">183</xref></sup> In a GWAS of cannabis dependence, there is a consistent overlap with potential genetic factors contributing to major depression and SCZ.<sup><xref ref-type="bibr" rid="bibr184-2470547020924844">184</xref></sup></p>
</sec>
</sec>
<sec id="sec21-2470547020924844">
<title>Conclusions and Future Directions</title>
<p>GWAS have contributed major advances to our understanding of the polygenic architecture of psychiatric disorders. However, the phenotypic and genetic heterogeneity described herein contribute to complicate the translation of genetic data into clinical practice. For example, sex differences are ubiquitous across psychiatric disorders but are only recently being investigated with genome-wide methods. Unfortunately, stratifying by sex drastically reduces sample size for a GWAS, but large-scale genomics consortia are rapidly collecting suitable sample sizes to make these analyses more feasible and reliable. Until then, the community may consider focusing attention on several additional sex-specific topic areas including X-chromosome studies and regulatory/expression studies of risk loci. X-chromosome association studies are still relatively novel and require additional consideration of dosage differences between sexes but hold great potential for uncovering differential disorder risks in males and females.<sup><xref ref-type="bibr" rid="bibr185-2470547020924844">185</xref><xref ref-type="bibr" rid="bibr186-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr187-2470547020924844">187</xref></sup> Furthermore, regulatory mechanisms have been identified as likely contributors to the sex differences in many disorders, but these processes remain vastly underinvestigated.<sup><xref ref-type="bibr" rid="bibr188-2470547020924844">188</xref><xref ref-type="bibr" rid="bibr189-2470547020924844"></xref>–<xref ref-type="bibr" rid="bibr190-2470547020924844">190</xref></sup> These studies will be particularly informative for understanding how genes discovered by GWAS are expressed in each sex.</p>
<p>We have summarized how phenotypic heterogeneity greatly influences genetic heterogeneity in psychiatry. The RDoC paradigm may help considerably reduce this heterogeneity by focusing on biologically tractable processes, measurements, and/or mechanisms rather than diagnoses dependent on multi-item symptom checklists.<sup><xref ref-type="bibr" rid="bibr49-2470547020924844">49</xref></sup> It is important to note that some of the existing GWAS of psychiatric disorders likely already incorporate some aspects of RDoC (e.g. (a) hyperarousal and reexperiencing symptoms of PTSD diagnosis<sup><xref ref-type="bibr" rid="bibr22-2470547020924844">22</xref></sup> and (b) studying hallucinations as a representative symptom of psychotic disorders<sup><xref ref-type="bibr" rid="bibr191-2470547020924844">191</xref></sup>).</p>
<p>GWAS of psychiatric disorders have elucidated thousands of risk loci contributing to disease etiology and generated countless testable hypothesis addressing psychiatric disorder heterogeneity, comorbidities, and cross-species interactions (e.g. microbiome-brain interactions). GWAS data, and therefore the resulting post-GWAS analyses, may be influenced by phenotype and sample heterogeneity which both have document effects on detection of the polygenic architecture of a trait. It is well understood that the polygenicity of a disorder in one population may not reflect the polygenicity of the same disorder in an external population. This observation means that findings from well-studied European populations may not, and indeed do not,<sup><xref ref-type="bibr" rid="bibr192-2470547020924844">192</xref></sup> translate effectively to non-Europeans and supports a discipline-wide effort to close this gap by studying psychiatric disorder polygenic architectures in other populations.</p>
</sec>
</body>
<back>
<sec id="sec22-2470547020924844">
<title>Declaration of Conflicting Interests</title>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</sec>
<sec id="sec23-2470547020924844">
<title>Funding</title>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors are supported by the National Institute on Drug Abuse (R21 DA047527), the National Institute National Institute on Deafness and Other Communication Disorders (R21 DC018098), and the National Center for Posttraumatic Stress Disorder of the U.S. Department of Veterans Affairs.</p>
</sec>
<sec>
<title>ORCID iDs</title>
<p>Frank R. Wendt <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-2108-6822">https://orcid.org/0000-0002-2108-6822</ext-link></p>
<p>Daniel S. Tylee <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-7579-6096">https://orcid.org/0000-0002-7579-6096</ext-link></p>
<p>Renato Polimanti <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-0745-6046">https://orcid.org/0000-0003-0745-6046</ext-link></p>
</sec>
<ref-list content-type="numbered">
<title>References</title>
<ref id="bibr1-2470547020924844">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buniello</surname><given-names>A</given-names></name><name><surname>MacArthur</surname><given-names>JAL</given-names></name><name><surname>Cerezo</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>
<article-title>The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019.</article-title>
<source/>Nucleic Acids Res. <year>2019</year>; 
<volume>47</volume>: <fpage>D1005</fpage>–<lpage>D1012</lpage>.<pub-id pub-id-type="pmid">30445434</pub-id></mixed-citation>
</ref>
<ref id="bibr2-2470547020924844">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbarian</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Knowles</surname><given-names>JA</given-names></name></person-group>, <etal>et al</etal>
<article-title>The PsychENCODE project.</article-title>
<source/>Nat Neurosci. <year>2015</year>; 
<volume>18</volume>: <fpage>1707</fpage>–<lpage>1712</lpage>.<pub-id pub-id-type="pmid">26605881</pub-id></mixed-citation>
</ref>
<ref id="bibr3-2470547020924844">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Taskesen</surname><given-names>E</given-names></name><name><surname>van Bochoven</surname><given-names>A</given-names></name><name><surname>Posthuma</surname><given-names>D.</given-names></name></person-group>
<article-title>Functional mapping and annotation of genetic associations with FUMA.</article-title>
<source/>Nat Commun. <year>2017</year>; 
<volume>8</volume>: <fpage>1826</fpage>.<pub-id pub-id-type="pmid">29184056</pub-id></mixed-citation>
</ref>
<ref id="bibr4-2470547020924844">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Umicevic Mirkov</surname><given-names>M</given-names></name><name><surname>de Leeuw</surname><given-names>CA</given-names></name><name><surname>van den Heuvel</surname><given-names>MP</given-names></name><name><surname>Posthuma</surname><given-names>D.</given-names></name></person-group>
<article-title>Genetic mapping of cell type specificity for complex traits.</article-title>
<source/>Nat Commun. <year>2019</year>; 
<volume>10</volume>: <fpage>3222</fpage>.<pub-id pub-id-type="pmid">31324783</pub-id></mixed-citation>
</ref>
<ref id="bibr5-2470547020924844">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>CD</given-names></name><name><surname>DeGiorgio</surname><given-names>M</given-names></name><name><surname>Hellmann</surname><given-names>I</given-names></name><name><surname>Nielsen</surname><given-names>R.</given-names></name></person-group>
<article-title>Detecting recent selective sweeps while controlling for mutation rate and background selection.</article-title>
<source/>Mol Ecol. <year>2016</year>; 
<volume>25</volume>: <fpage>142</fpage>–<lpage>156</lpage>.<pub-id pub-id-type="pmid">26290347</pub-id></mixed-citation>
</ref>
<ref id="bibr6-2470547020924844">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hujoel</surname><given-names>MLA</given-names></name><name><surname>Gazal</surname><given-names>S</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>van de Geijn</surname><given-names>B</given-names></name><name><surname>Price</surname><given-names>AL.</given-names></name></person-group>
<article-title>Disease heritability enrichment of regulatory elements is concentrated in elements with ancient sequence age and conserved function across species.</article-title>
<source/>Am J Hum Genet. <year>2019</year>; 
<volume>104</volume>: <fpage>611</fpage>–<lpage>624</lpage>.<pub-id pub-id-type="pmid">30905396</pub-id></mixed-citation>
</ref>
<ref id="bibr7-2470547020924844">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Connor</surname><given-names>LJ</given-names></name><name><surname>Schoech</surname><given-names>AP</given-names></name><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Gazal</surname><given-names>S</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Price</surname><given-names>AL.</given-names></name></person-group>
<article-title>Extreme polygenicity of complex traits is explained by negative selection.</article-title>
<source/>Am J Hum Genet. <year>2019</year>; 
<volume>105</volume>: <fpage>456</fpage>–<lpage>476</lpage>.<pub-id pub-id-type="pmid">31402091</pub-id></mixed-citation>
</ref>
<ref id="bibr8-2470547020924844">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardinas</surname><given-names>AF</given-names></name><name><surname>Holmans</surname><given-names>P</given-names></name><name><surname>Pocklington</surname><given-names>AJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.</article-title>
<source/>Nat Genet. <year>2018</year>; 
<volume>50</volume>: <fpage>381</fpage>–<lpage>389</lpage>.<pub-id pub-id-type="pmid">29483656</pub-id></mixed-citation>
</ref>
<ref id="bibr9-2470547020924844">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polimanti</surname><given-names>R</given-names></name><name><surname>Gelernter</surname><given-names>J.</given-names></name></person-group>
<article-title>Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder</article-title>. <source/>PLoS Genet. <year>2017</year>; 
<volume>13</volume>: <fpage>e1006618</fpage>.<pub-id pub-id-type="pmid">28187187</pub-id></mixed-citation>
</ref>
<ref id="bibr10-2470547020924844">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>J</given-names></name><name><surname>Del Greco</surname><given-names>MF</given-names></name><name><surname>Minelli</surname><given-names>C</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Sheehan</surname><given-names>N</given-names></name><name><surname>Thompson</surname><given-names>J.</given-names></name></person-group>
<article-title>A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization.</article-title>
<source/>Stat Med. <year>2017</year>; 
<volume>36</volume>: <fpage>1783</fpage>–<lpage>1802</lpage>.<pub-id pub-id-type="pmid">28114746</pub-id></mixed-citation>
</ref>
<ref id="bibr11-2470547020924844">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name></person-group>, <etal>et al</etal>
<article-title>An atlas of genetic correlations across human diseases and traits.</article-title>
<source/>Nat Genet. <year>2015</year>; 
<volume>47</volume>: <fpage>1236</fpage>–<lpage>1241</lpage>.<pub-id pub-id-type="pmid">26414676</pub-id></mixed-citation>
</ref>
<ref id="bibr12-2470547020924844">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulik-Sullivan</surname><given-names>BK</given-names></name><name><surname>Loh</surname><given-names>PR</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name></person-group>, <etal>et al</etal>
<article-title>LD score regression distinguishes confounding from polygenicity in genome-wide association studies.</article-title>
<source/>Nat Genet. <year>2015</year>; 
<volume>47</volume>: <fpage>291</fpage>–<lpage>295</lpage>.<pub-id pub-id-type="pmid">25642630</pub-id></mixed-citation>
</ref>
<ref id="bibr13-2470547020924844">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebrahim</surname><given-names>S</given-names></name><name><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group>
<article-title>Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?</article-title>
<source/>Hum Genet. <year>2008</year>; 
<volume>123</volume>: <fpage>15</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">18038153</pub-id></mixed-citation>
</ref>
<ref id="bibr14-2470547020924844">
<label>14</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>O’Connor</surname><given-names>LJ</given-names></name><name><surname>Price</surname><given-names>AL.</given-names></name></person-group> Distinguishing genetic correlation from causation across 52 diseases and complex traits. <italic>Nat Genet</italic>
<year>2018</year>; 50: 1728–1734.</mixed-citation>
</ref>
<ref id="bibr15-2470547020924844">
<label>15</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Wendt</surname><given-names>FR</given-names></name><name><surname>Pathak</surname><given-names>GA</given-names></name><name><surname>Lencz</surname><given-names>T</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Polimanti</surname><given-names>R.</given-names></name></person-group> Dissecting the genetic overlap of education, socioeconomic status, and mental health. <italic>medRxiv</italic>
<year>2020</year>; 2020.01.09.20017079.</mixed-citation>
</ref>
<ref id="bibr16-2470547020924844">
<label>16</label>
<mixed-citation publication-type="journal"><collab>Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium.</collab>
<article-title>Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes</article-title>. <source/>Cell. <year>2018</year>; 
<volume>173</volume>: <fpage>1705</fpage>–<lpage>1715</lpage>.e16.<pub-id pub-id-type="pmid">29906448</pub-id></mixed-citation>
</ref>
<ref id="bibr17-2470547020924844">
<label>17</label>
<mixed-citation publication-type="journal">Cross-Disorder Group of the Psychiatric Genomics Consortium. 
<article-title>Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders</article-title>. <source/>Cell. <year>2019</year>; 
<volume>179</volume>: <fpage>1469</fpage>–<lpage>1482.e11</lpage>.<pub-id pub-id-type="pmid">31835028</pub-id></mixed-citation>
</ref>
<ref id="bibr18-2470547020924844">
<label>18</label>
<mixed-citation publication-type="journal"><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium.</collab>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source/>Nature. <year>2014</year>; 
<volume>511</volume>: <fpage>421</fpage>–<lpage>427</lpage>.<pub-id pub-id-type="pmid">25056061</pub-id></mixed-citation>
</ref>
<ref id="bibr19-2470547020924844">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demontis</surname><given-names>D</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>
<article-title>Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.</article-title>
<source/>Nat Genet. <year>2019</year>; 
<volume>51</volume>: <fpage>63</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">30478444</pub-id></mixed-citation>
</ref>
<ref id="bibr20-2470547020924844">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Kranzler</surname><given-names>HR</given-names></name><name><surname>Sherva</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways</article-title>. <source/>Biol Psychiatry. <year>2014</year>; 
<volume>76</volume>: <fpage>66</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">24143882</pub-id></mixed-citation>
</ref>
<ref id="bibr21-2470547020924844">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Sherva</surname><given-names>R</given-names></name><name><surname>Koesterer</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene.</article-title>
<source/>Mol Psychiatry. <year>2014</year>; 
<volume>19</volume>: <fpage>717</fpage>–<lpage>723</lpage>.<pub-id pub-id-type="pmid">23958962</pub-id></mixed-citation>
</ref>
<ref id="bibr22-2470547020924844">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Polimanti</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in &gt;165,000 US veterans</article-title>. <source/>Nat Neurosci. <year>2019</year>; 
<volume>22</volume>: <fpage>1394</fpage>–1<lpage>401</lpage>.<pub-id pub-id-type="pmid">31358989</pub-id></mixed-citation>
</ref>
<ref id="bibr23-2470547020924844">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grove</surname><given-names>J</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Als</surname><given-names>TD</given-names></name></person-group>, <etal>et al</etal>
<article-title>Identification of common genetic risk variants for autism spectrum disorder.</article-title>
<source/>Nat Genet. <year>2019</year>; 
<volume>51</volume>: <fpage>431</fpage>–<lpage>444</lpage>.<pub-id pub-id-type="pmid">30804558</pub-id></mixed-citation>
</ref>
<ref id="bibr24-2470547020924844">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>DM</given-names></name><name><surname>Adams</surname><given-names>MJ</given-names></name><name><surname>Clarke</surname><given-names>TK</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions.</article-title>
<source/>Nat Neurosci. <year>2019</year>; 
<volume>22</volume>: <fpage>343</fpage>–<lpage>352</lpage>.<pub-id pub-id-type="pmid">30718901</pub-id></mixed-citation>
</ref>
<ref id="bibr25-2470547020924844">
<label>25</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>DF</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Polimanti</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal> Reproducible genetic risk loci for anxiety: results from approximately 200,000 participants in the million veteran program. <italic>Am J Psychiatry.</italic>
<year>2020</year>; 177: 223–232.</mixed-citation>
</ref>
<ref id="bibr26-2470547020924844">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Wedow</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>
<article-title>Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use.</article-title>
<source/>Nat Genet. <year>2019</year>; 
<volume>51</volume>: <fpage>237</fpage>–<lpage>244</lpage>.<pub-id pub-id-type="pmid">30643251</pub-id></mixed-citation>
</ref>
<ref id="bibr27-2470547020924844">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nievergelt</surname><given-names>CM</given-names></name><name><surname>Maihofer</surname><given-names>AX</given-names></name><name><surname>Klengel</surname><given-names>T</given-names></name></person-group>, <etal>et al</etal>
<article-title>International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci.</article-title>
<source/>Nat Commun. <year>2019</year>; 
<volume>10</volume>: <fpage>4558</fpage>.<pub-id pub-id-type="pmid">31594949</pub-id></mixed-citation>
</ref>
<ref id="bibr28-2470547020924844">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasman</surname><given-names>JA</given-names></name><name><surname>Verweij</surname><given-names>KJH</given-names></name><name><surname>Gerring</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal>
<article-title>GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.</article-title>
<source/>Nat Neurosci. <year>2018</year>; 
<volume>21</volume>: <fpage>1161</fpage>–<lpage>1170</lpage>.<pub-id pub-id-type="pmid">30150663</pub-id></mixed-citation>
</ref>
<ref id="bibr29-2470547020924844">
<label>29</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Polimanti</surname><given-names>R</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Johnson</surname><given-names>EC</given-names></name></person-group>, <etal>et al</etal> Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium. <italic>bioRxiv</italic>
<year>2019</year>; 765065.</mixed-citation>
</ref>
<ref id="bibr30-2470547020924844">
<label>30</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>MB</given-names></name><name><surname>Levey</surname><given-names>DF</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal> Genomic characterization of posttraumatic stress disorder in a large US military veteran sample. <italic>bioRxiv</italic>
<year>2019</year>; <fpage>764001</fpage>.</mixed-citation>
</ref>
<ref id="bibr31-2470547020924844">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>HJ</given-names></name><name><surname>Yilmaz</surname><given-names>Z</given-names></name><name><surname>Thornton</surname><given-names>LM</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa.</article-title>
<source/>Nat Genet. <year>2019</year>; 
<volume>51</volume>: <fpage>1207</fpage>–<lpage>1214</lpage>.<pub-id pub-id-type="pmid">31308545</pub-id></mixed-citation>
</ref>
<ref id="bibr32-2470547020924844">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Mattheisen</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.</article-title>
<source/>Nat Genet. <year>2018</year>; 
<volume>50</volume>: <fpage>668</fpage>–<lpage>681</lpage>.<pub-id pub-id-type="pmid">29700475</pub-id></mixed-citation>
</ref>
<ref id="bibr33-2470547020924844">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Sul</surname><given-names>JH</given-names></name><name><surname>Tsetsos</surname><given-names>F</given-names></name></person-group>, <etal>et al</etal>
<article-title>Interrogating the genetic determinants of Tourette’s syndrome and other tic disorders through genome-wide association studies.</article-title>
<source/>Am J Psychiatry. <year>2019</year>; 
<volume>176</volume>: <fpage>217</fpage>–<lpage>227</lpage>.<pub-id pub-id-type="pmid">30818990</pub-id></mixed-citation>
</ref>
<ref id="bibr34-2470547020924844">
<label>34</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Rentsch</surname><given-names>CT</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal> GWAS including 82,707 subjects identifies functional coding variant in OPRM1 gene associated with opioid use disorder. <italic>medRxiv.</italic>
<year>2019</year>; <fpage>19007039</fpage>.</mixed-citation>
</ref>
<ref id="bibr35-2470547020924844">
<label>35</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Sealock</surname><given-names>JM</given-names></name><name><surname>Sanchez-Roige</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal> Meta-analysis of problematic alcohol use in 435,563 individuals identifies 29 risk variants and yields insights into biology, pleiotropy and causality. <italic>bioRxiv</italic>
<year>2019</year>; 738088.</mixed-citation>
</ref>
<ref id="bibr36-2470547020924844">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>EA</given-names></name><name><surname>Li</surname><given-names>YI</given-names></name><name><surname>Pritchard</surname><given-names>JK.</given-names></name></person-group>
<article-title>An expanded view of complex traits: from polygenic to omnigenic.</article-title>
<source/>Cell. <year>2017</year>; 
<volume>169</volume>: <fpage>1177</fpage>–<lpage>1186</lpage>.<pub-id pub-id-type="pmid">28622505</pub-id></mixed-citation>
</ref>
<ref id="bibr37-2470547020924844">
<label>37</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Jian</surname><given-names>X</given-names></name><name><surname>Kunkle</surname><given-names>BW</given-names></name></person-group>, <etal>et al</etal> Whole exome sequencing study identifies novel rare and common Alzheimer’s-associated variants involved in immune response and transcriptional regulation. <italic>Mol Psychiatry</italic>
<year>2018</year>.</mixed-citation>
</ref>
<ref id="bibr38-2470547020924844">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>DJ</given-names></name><name><surname>Wigdor</surname><given-names>EM</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>
<article-title>Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders.</article-title>
<source/>Nat Genet. <year>2017</year>; 
<volume>49</volume>: <fpage>978</fpage>–<lpage>985</lpage>.<pub-id pub-id-type="pmid">28504703</pub-id></mixed-citation>
</ref>
<ref id="bibr39-2470547020924844">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name></person-group>, <etal>et al</etal>
<article-title>Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder</article-title>. <source/>Transl Psychiatry. <year>2018</year>; 
<volume>8</volume>: <fpage>70</fpage>.<pub-id pub-id-type="pmid">29581422</pub-id></mixed-citation>
</ref>
<ref id="bibr40-2470547020924844">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>M</given-names></name><name><surname>Awasthi</surname><given-names>S</given-names></name><name><surname>Watson</surname><given-names>HJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>RICOPILI: Rapid Imputation for COnsortias PIpeLIne.</article-title>
<source/>Bioinformatics. <year>2020</year>; 
<volume>36</volume>: <fpage>930</fpage>–93<lpage>3</lpage>.<pub-id pub-id-type="pmid">31393554</pub-id></mixed-citation>
</ref>
<ref id="bibr41-2470547020924844">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marees</surname><given-names>AT</given-names></name><name><surname>de Kluiver</surname><given-names>H</given-names></name><name><surname>Stringer</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>
<article-title>A tutorial on conducting genome-wide association studies: quality control and statistical analysis.</article-title>
<source/>Int J Methods Psychiatr Res. <year>2018</year>; 
<volume>27</volume>: <fpage>e1608</fpage>.<pub-id pub-id-type="pmid">29484742</pub-id></mixed-citation>
</ref>
<ref id="bibr42-2470547020924844">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>LA</given-names></name><name><surname>Cuthbert</surname><given-names>B</given-names></name><name><surname>Lewis-Fernandez</surname><given-names>R</given-names></name><name><surname>Narrow</surname><given-names>WE</given-names></name><name><surname>Reed</surname><given-names>GM.</given-names></name></person-group>
<article-title>Three approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of Mental Health’s Research Domain Criteria (RDoC).</article-title>
<source/>Psychol Sci Public Interest. <year>2017</year>; 
<volume>18</volume>: <fpage>72</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">29211974</pub-id></mixed-citation>
</ref>
<ref id="bibr43-2470547020924844">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cartwright</surname><given-names>DJ.</given-names></name></person-group>
<article-title>ICD-9-CM to ICD-10-CM codes: What? Why? How?</article-title>
<source/>Adv Wound Care (New Rochelle). <year>2013</year>; 
<volume>2</volume>: <fpage>588</fpage>–<lpage>592</lpage>.<pub-id pub-id-type="pmid">24761333</pub-id></mixed-citation>
</ref>
<ref id="bibr44-2470547020924844">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Malley</surname><given-names>KJ</given-names></name><name><surname>Cook</surname><given-names>KF</given-names></name><name><surname>Price</surname><given-names>MD</given-names></name><name><surname>Wildes</surname><given-names>KR</given-names></name><name><surname>Hurdle</surname><given-names>JF</given-names></name><name><surname>Ashton</surname><given-names>CM.</given-names></name></person-group>
<article-title>Measuring diagnoses: ICD code accuracy.</article-title>
<source/>Health Serv Res. <year>2005</year>; 
<volume>40</volume>: <fpage>1620</fpage>–<lpage>1639</lpage>.<pub-id pub-id-type="pmid">16178999</pub-id></mixed-citation>
</ref>
<ref id="bibr45-2470547020924844">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regier</surname><given-names>DA</given-names></name><name><surname>Kuhl</surname><given-names>EA</given-names></name><name><surname>Kupfer</surname><given-names>DJ.</given-names></name></person-group>
<article-title>The DSM-5: classification and criteria changes.</article-title>
<source/>World Psychiatry. <year>2013</year>; 
<volume>12</volume>: <fpage>92</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">23737408</pub-id></mixed-citation>
</ref>
<ref id="bibr46-2470547020924844">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adornetto</surname><given-names>C</given-names></name><name><surname>Suppiger</surname><given-names>A</given-names></name><name><surname>In-Albon</surname><given-names>T</given-names></name><name><surname>Neuschwander</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>S.</given-names></name></person-group>
<article-title>Concordances and discrepancies between ICD-10 and DSM-IV criteria for anxiety disorders in childhood and adolescence.</article-title>
<source/>Child Adolesc Psychiatry Ment Health. <year>2012</year>; 
<volume>6</volume>: <fpage>40</fpage>.<pub-id pub-id-type="pmid">23267678</pub-id></mixed-citation>
</ref>
<ref id="bibr47-2470547020924844">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suris</surname><given-names>A</given-names></name><name><surname>Holliday</surname><given-names>R</given-names></name><name><surname>North</surname><given-names>CS.</given-names></name></person-group>
<article-title>The evolution of the classification of psychiatric disorders</article-title>. <source/>Behav Sci (Basel). <year>2016</year>; 
<volume>6</volume>.</mixed-citation>
</ref>
<ref id="bibr48-2470547020924844">
<label>48</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Wendt</surname><given-names>FR</given-names></name><name><surname>Pathak</surname><given-names>GA</given-names></name><name><surname>Overstreet</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal> Natural selection influenced the genetic architecture of brain structure, behavioral and neuropsychiatric traits. <italic>bioRxiv</italic>
<year>2020</year>; 2020.02.26.966531.</mixed-citation>
</ref>
<ref id="bibr49-2470547020924844">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montalvo-Ortiz</surname><given-names>JL</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Hudziak</surname><given-names>J</given-names></name><name><surname>Kaufman</surname><given-names>J.</given-names></name></person-group>
<article-title>RDoC and translational perspectives on the genetics of trauma-related psychiatric disorders.</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet. <year>2016</year>; 
<volume>171B</volume>: <fpage>81</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">26592203</pub-id></mixed-citation>
</ref>
<ref id="bibr50-2470547020924844">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>JR</given-names></name><name><surname>Sommer</surname><given-names>B.</given-names></name></person-group>
<article-title>The research domain criteria framework in drug discovery for neuropsychiatric diseases: focus on negative valence.</article-title>
<source/>Brain Neurosci Adv. <year>2018</year>; 
<volume>2</volume>: <fpage>2398212818804030</fpage>.<pub-id pub-id-type="pmid">32166151</pub-id></mixed-citation>
</ref>
<ref id="bibr51-2470547020924844">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnbaum</surname><given-names>R</given-names></name><name><surname>Weinberger</surname><given-names>DR.</given-names></name></person-group>
<article-title>Genetic insights into the neurodevelopmental origins of schizophrenia.</article-title>
<source/>Nat Rev Neurosci. <year>2017</year>; 
<volume>18</volume>: <fpage>727</fpage>–<lpage>740</lpage>.<pub-id pub-id-type="pmid">29070826</pub-id></mixed-citation>
</ref>
<ref id="bibr52-2470547020924844">
<label>52</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Jablensky</surname><given-names>A</given-names></name><name><surname>Kirkbride</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>PB.</given-names></name></person-group> Schizophrenia: the epidemiological horizon. In: Weinberger DR and Harrison PJ, eds. <italic>Schizophrenia</italic> Wiley-Blackwell; <year>2011</year>: 185–225.</mixed-citation>
</ref>
<ref id="bibr53-2470547020924844">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marder</surname><given-names>SR</given-names></name><name><surname>Galderisi</surname><given-names>S.</given-names></name></person-group>
<article-title>The current conceptualization of negative symptoms in schizophrenia.</article-title>
<source/>World Psychiatry. <year>2017</year>; 
<volume>16</volume>: <fpage>14</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">28127915</pub-id></mixed-citation>
</ref>
<ref id="bibr54-2470547020924844">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>KR</given-names></name><name><surname>Cherian</surname><given-names>J</given-names></name><name><surname>Gohil</surname><given-names>K</given-names></name><name><surname>Atkinson</surname><given-names>D.</given-names></name></person-group>
<article-title>Schizophrenia: overview and treatment options</article-title>. <source/>P T. <year>2014</year>; 
<volume>39</volume>: <fpage>638</fpage>–<lpage>645</lpage>.<pub-id pub-id-type="pmid">25210417</pub-id></mixed-citation>
</ref>
<ref id="bibr55-2470547020924844">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>G</given-names></name><name><surname>Slachevsky</surname><given-names>A.</given-names></name></person-group>
<article-title>Executive functioning in schizophrenia</article-title>. <source/>Front Psychiatry. <year>2013</year>; 
<volume>4</volume>: <fpage>35</fpage>.<pub-id pub-id-type="pmid">23805107</pub-id></mixed-citation>
</ref>
<ref id="bibr56-2470547020924844">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>AR</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Robinson</surname><given-names>EB</given-names></name><name><surname>Hyman</surname><given-names>SE</given-names></name><name><surname>Neale</surname><given-names>BM.</given-names></name></person-group>
<article-title>Predicting polygenic risk of psychiatric disorders.</article-title>
<source/>Biol Psychiatry. <year>2019</year>; 
<volume>86</volume>: <fpage>97</fpage>–<lpage>109</lpage>.<pub-id pub-id-type="pmid">30737014</pub-id></mixed-citation>
</ref>
<ref id="bibr57-2470547020924844">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Geschwind</surname><given-names>DH.</given-names></name></person-group>
<article-title>Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders.</article-title>
<source/>Cell. <year>2019</year>; 
<volume>177</volume>: <fpage>162</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">30901538</pub-id></mixed-citation>
</ref>
<ref id="bibr58-2470547020924844">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>PR</given-names></name><name><surname>Bhatia</surname><given-names>G</given-names></name><name><surname>Gusev</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>
<article-title>Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis.</article-title>
<source/>Nat Genet. <year>2015</year>; 
<volume>47</volume>: <fpage>1385</fpage>–<lpage>1392</lpage>.<pub-id pub-id-type="pmid">26523775</pub-id></mixed-citation>
</ref>
<ref id="bibr59-2470547020924844">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokhtari</surname><given-names>R</given-names></name><name><surname>Lachman</surname><given-names>HM.</given-names></name></person-group>
<article-title>The major histocompatibility complex (MHC) in schizophrenia: a review</article-title>. <source/>J Clin Cell Immunol. <year>2016</year>; 
<volume>7</volume>.</mixed-citation>
</ref>
<ref id="bibr60-2470547020924844">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekar</surname><given-names>A</given-names></name><name><surname>Bialas</surname><given-names>AR</given-names></name><name><surname>de Rivera</surname><given-names>H</given-names></name></person-group>, <etal>et al</etal>
<article-title>Schizophrenia risk from complex variation of complement component 4.</article-title>
<source/>Nature. <year>2016</year>; 
<volume>530</volume>: <fpage>177</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">26814963</pub-id></mixed-citation>
</ref>
<ref id="bibr61-2470547020924844">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>ML</given-names></name><name><surname>Alhassan</surname><given-names>J</given-names></name><name><surname>Newman</surname><given-names>JT</given-names></name></person-group>, <etal>et al</etal>
<article-title>Selective loss of smaller spines in schizophrenia.</article-title>
<source/>Am J Psychiatry. <year>2017</year>; 
<volume>174</volume>: <fpage>586</fpage>–<lpage>594</lpage>.<pub-id pub-id-type="pmid">28359200</pub-id></mixed-citation>
</ref>
<ref id="bibr62-2470547020924844">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>A</given-names></name><name><surname>Kar</surname><given-names>SK</given-names></name><name><surname>Shukla</surname><given-names>R.</given-names></name></person-group>
<article-title>Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies.</article-title>
<source/>Clin Psychopharmacol Neurosci. <year>2018</year>; 
<volume>16</volume>: <fpage>7</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">29397662</pub-id></mixed-citation>
</ref>
<ref id="bibr63-2470547020924844">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohi</surname><given-names>K</given-names></name><name><surname>Sumiyoshi</surname><given-names>C</given-names></name><name><surname>Fujino</surname><given-names>H</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genetic overlap between general cognitive function and schizophrenia: a review of cognitive GWASs</article-title>. <source/>Int J Mol Sci. <year>2018</year>; 
<volume>19</volume>.</mixed-citation>
</ref>
<ref id="bibr64-2470547020924844">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>V</given-names></name><name><surname>Mitjans</surname><given-names>M</given-names></name><name><surname>Burik</surname><given-names>CAP</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia.</article-title>
<source/>Nat Commun. <year>2018</year>; 
<volume>9</volume>: <fpage>3078</fpage>.<pub-id pub-id-type="pmid">30082721</pub-id></mixed-citation>
</ref>
<ref id="bibr65-2470547020924844">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craddock</surname><given-names>N</given-names></name><name><surname>Sklar</surname><given-names>P.</given-names></name></person-group>
<article-title>Genetics of bipolar disorder: successful start to a long journey.</article-title>
<source/>Trends Genet. <year>2009</year>; 
<volume>25</volume>: <fpage>99</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">19144440</pub-id></mixed-citation>
</ref>
<ref id="bibr66-2470547020924844">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Forstner</surname><given-names>AJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study identifies 30 loci associated with bipolar disorder</article-title>. <source/>Nat Genet. <year>2019</year>; 
<volume>51</volume>: <fpage>793</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="pmid">31043756</pub-id></mixed-citation>
</ref>
<ref id="bibr67-2470547020924844">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>MB</given-names></name><name><surname>Ware</surname><given-names>EB</given-names></name><name><surname>Mitchell</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genomewide association studies of suicide attempts in US soldiers.</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet. <year>2017</year>; 
<volume>174</volume>: <fpage>786</fpage>–<lpage>797</lpage>.<pub-id pub-id-type="pmid">28902444</pub-id></mixed-citation>
</ref>
<ref id="bibr68-2470547020924844">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culpepper</surname><given-names>L.</given-names></name></person-group>
<article-title>The diagnosis and treatment of bipolar disorder: decision-making in primary care</article-title>. <source/>Prim Care Companion CNS Disord. <year>2014</year>; 
<volume>16</volume>.</mixed-citation>
</ref>
<ref id="bibr69-2470547020924844">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datto</surname><given-names>C</given-names></name><name><surname>Pottorf</surname><given-names>WJ</given-names></name><name><surname>Feeley</surname><given-names>L</given-names></name><name><surname>LaPorte</surname><given-names>S</given-names></name><name><surname>Liss</surname><given-names>C.</given-names></name></person-group>
<article-title>Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression.</article-title>
<source/>Ann Gen Psychiatry. <year>2016</year>; 
<volume>15</volume>: <fpage>9</fpage>.<pub-id pub-id-type="pmid">26973704</pub-id></mixed-citation>
</ref>
<ref id="bibr70-2470547020924844">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charney</surname><given-names>AW</given-names></name><name><surname>Ruderfer</surname><given-names>DM</given-names></name><name><surname>Stahl</surname><given-names>EA</given-names></name></person-group>, <etal>et al</etal>
<article-title>Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.</article-title>
<source/>Transl Psychiatry. <year>2017</year>; 
<volume>7</volume>: <fpage>e993</fpage>.<pub-id pub-id-type="pmid">28072414</pub-id></mixed-citation>
</ref>
<ref id="bibr71-2470547020924844">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markota</surname><given-names>M</given-names></name><name><surname>Coombes</surname><given-names>BJ</given-names></name><name><surname>Larrabee</surname><given-names>BR</given-names></name></person-group>, <etal>et al</etal>
<article-title>Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder.</article-title>
<source/>Transl Psychiatry. <year>2018</year>; 
<volume>8</volume>: <fpage>188</fpage>.<pub-id pub-id-type="pmid">30201969</pub-id></mixed-citation>
</ref>
<ref id="bibr72-2470547020924844">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musliner</surname><given-names>KL</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>McGrath</surname><given-names>JJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>Association of polygenic liabilities for major depression, bipolar disorder, and schizophrenia with risk for depression in the Danish population.</article-title>
<source/>JAMA Psychiatry. <year>2019</year>; 
<volume>76</volume>: <fpage>516</fpage>–<lpage>525</lpage>.<pub-id pub-id-type="pmid">30698613</pub-id></mixed-citation>
</ref>
<ref id="bibr73-2470547020924844">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willcutt</surname><given-names>EG.</given-names></name></person-group>
<article-title>The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review.</article-title>
<source/>Neurotherapeutics. <year>2012</year>; 
<volume>9</volume>: <fpage>490</fpage>–<lpage>499</lpage>.<pub-id pub-id-type="pmid">22976615</pub-id></mixed-citation>
</ref>
<ref id="bibr74-2470547020924844">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Strathearn</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Bao</surname><given-names>W.</given-names></name></person-group>
<article-title>Twenty-year trends in diagnosed attention-deficit/hyperactivity disorder among US children and adolescents, 1997–2016</article-title>. <source/>JAMA Netw Open. <year>2018</year>; 
<volume>1</volume>: <fpage>e181471</fpage>.<pub-id pub-id-type="pmid">30646132</pub-id></mixed-citation>
</ref>
<ref id="bibr75-2470547020924844">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Larsson</surname><given-names>H.</given-names></name></person-group>
<article-title>Genetics of attention deficit hyperactivity disorder.</article-title>
<source/>Mol Psychiatry. <year>2019</year>; 
<volume>24</volume>: <fpage>562</fpage>–<lpage>575</lpage>.<pub-id pub-id-type="pmid">29892054</pub-id></mixed-citation>
</ref>
<ref id="bibr76-2470547020924844">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>AB</given-names></name><name><surname>Pennington</surname><given-names>BF</given-names></name><name><surname>Willcutt</surname><given-names>EG</given-names></name><name><surname>DeFries</surname><given-names>JC</given-names></name><name><surname>Olson</surname><given-names>RK.</given-names></name></person-group>
<article-title>Sex differences in ADHD symptom severity.</article-title>
<source/>J Child Psychol Psychiatry. <year>2015</year>; 
<volume>56</volume>: <fpage>632</fpage>–<lpage>639</lpage>.<pub-id pub-id-type="pmid">25283790</pub-id></mixed-citation>
</ref>
<ref id="bibr77-2470547020924844">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>W.</given-names></name></person-group>
<article-title>Sex differences in attention deficit hyperactivity disorder: candidate genetic and endocrine mechanisms.</article-title>
<source/>Front Neuroendocrinol. <year>2014</year>; 
<volume>35</volume>: <fpage>331</fpage>–<lpage>346</lpage>.<pub-id pub-id-type="pmid">24680800</pub-id></mixed-citation>
</ref>
<ref id="bibr78-2470547020924844">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Demontis</surname><given-names>D</given-names></name></person-group>, <etal>et al</etal>
<article-title>A genetic investigation of sex bias in the prevalence of attention-deficit/hyperactivity disorder.</article-title>
<source/>Biol Psychiatry. <year>2018</year>; 
<volume>83</volume>: <fpage>1044</fpage>–<lpage>1053</lpage>.<pub-id pub-id-type="pmid">29325848</pub-id></mixed-citation>
</ref>
<ref id="bibr79-2470547020924844">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramtekkar</surname><given-names>UP</given-names></name><name><surname>Reiersen</surname><given-names>AM</given-names></name><name><surname>Todorov</surname><given-names>AA</given-names></name><name><surname>Todd</surname><given-names>RD.</given-names></name></person-group>
<article-title>Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11</article-title>. <source/>J Am Acad Child Adolesc Psychiatry. <year>2010</year>; 
<volume>49</volume>: 217–228.e1-3.</mixed-citation>
</ref>
<ref id="bibr80-2470547020924844">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polderman</surname><given-names>TJ</given-names></name><name><surname>Hoekstra</surname><given-names>RA</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>Larsson</surname><given-names>H.</given-names></name></person-group>
<article-title>The co-occurrence of autistic and ADHD dimensions in adults: an etiological study in 17,770 twins.</article-title>
<source/>Transl Psychiatry. <year>2014</year>; 
<volume>4</volume>: <fpage>e435</fpage>.<pub-id pub-id-type="pmid">25180574</pub-id></mixed-citation>
</ref>
<ref id="bibr81-2470547020924844">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skogli</surname><given-names>EW</given-names></name><name><surname>Teicher</surname><given-names>MH</given-names></name><name><surname>Andersen</surname><given-names>PN</given-names></name><name><surname>Hovik</surname><given-names>KT</given-names></name><name><surname>Oie</surname><given-names>M.</given-names></name></person-group>
<article-title>ADHD in girls and boys–gender differences in co-existing symptoms and executive function measures.</article-title>
<source/>BMC Psychiatry. <year>2013</year>; 
<volume>13</volume>: <fpage>298</fpage>.<pub-id pub-id-type="pmid">24206839</pub-id></mixed-citation>
</ref>
<ref id="bibr82-2470547020924844">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>MJ</given-names></name><name><surname>Rydell</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>
<article-title>Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population.</article-title>
<source/>J Child Psychol Psychiatry. <year>2018</year>; 
<volume>59</volume>: <fpage>908</fpage>–<lpage>916</lpage>.<pub-id pub-id-type="pmid">29451303</pub-id></mixed-citation>
</ref>
<ref id="bibr83-2470547020924844">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>MJ</given-names></name><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Larsson</surname><given-names>H</given-names></name><name><surname>Anckarsater</surname><given-names>H</given-names></name><name><surname>Greven</surname><given-names>CU</given-names></name><name><surname>Ronald</surname><given-names>A.</given-names></name></person-group>
<article-title>Is there a female protective effect against attention-deficit/hyperactivity disorder? Evidence from two representative twin samples</article-title>. <source/>J Am Acad Child Adolesc Psychiatry. <year>2016</year>; 
<volume>55</volume>: <fpage>504</fpage>–<lpage>512.e2</lpage>.<pub-id pub-id-type="pmid">27238069</pub-id></mixed-citation>
</ref>
<ref id="bibr84-2470547020924844">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du Rietz</surname><given-names>E</given-names></name><name><surname>Coleman</surname><given-names>J</given-names></name><name><surname>Glanville</surname><given-names>K</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>O’Reilly</surname><given-names>PF</given-names></name><name><surname>Kuntsi</surname><given-names>J.</given-names></name></person-group>
<article-title>Association of polygenic risk for attention-deficit/hyperactivity disorder with co-occurring traits and disorders.</article-title>
<source/>Biol Psychiatry Cogn Neurosci Neuroimaging. <year>2018</year>; 
<volume>3</volume>: <fpage>635</fpage>–<lpage>643</lpage>.<pub-id pub-id-type="pmid">30047479</pub-id></mixed-citation>
</ref>
<ref id="bibr85-2470547020924844">
<label>85</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Brikell</surname><given-names>I</given-names></name><name><surname>Larsson</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name></person-group>, <etal>et al</etal> The contribution of common genetic risk variants for ADHD to a general factor of childhood psychopathology. <italic>Mol Psychiatry</italic>
<year>2018</year>.</mixed-citation>
</ref>
<ref id="bibr86-2470547020924844">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>J</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Bailey</surname><given-names>MES</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide analysis in UK biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia.</article-title>
<source/>Transl Psychiatry. <year>2017</year>; 
<volume>7</volume>: <fpage>1264</fpage>.<pub-id pub-id-type="pmid">29187730</pub-id></mixed-citation>
</ref>
<ref id="bibr87-2470547020924844">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabinowitz</surname><given-names>JA</given-names></name><name><surname>Musci</surname><given-names>RJ</given-names></name><name><surname>Milam</surname><given-names>AJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>The interplay between externalizing disorders polygenic risk scores and contextual factors on the development of marijuana use disorders.</article-title>
<source/>Drug Alcohol Depend. <year>2018</year>; 
<volume>191</volume>: <fpage>365</fpage>–<lpage>373</lpage>.<pub-id pub-id-type="pmid">30195949</pub-id></mixed-citation>
</ref>
<ref id="bibr88-2470547020924844">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendt</surname><given-names>FR</given-names></name><name><surname>Muniz Carvalho</surname><given-names>C</given-names></name><name><surname>Pathak</surname><given-names>GA</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Polimanti</surname><given-names>R</given-names></name></person-group>
<article-title>. Deciphering the biological mechanisms underlying the genome-wide associations between computerized device use and psychiatric disorders</article-title>. <source/>J Clin Med. <year>2019</year>; 
<volume>8</volume>.</mixed-citation>
</ref>
<ref id="bibr89-2470547020924844">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olbert</surname><given-names>CM</given-names></name><name><surname>Gala</surname><given-names>GJ</given-names></name><name><surname>Tupler</surname><given-names>LA.</given-names></name></person-group>
<article-title>Quantifying heterogeneity attributable to polythetic diagnostic criteria: theoretical framework and empirical application.</article-title>
<source/>J Abnorm Psychol. <year>2014</year>; 
<volume>123</volume>: <fpage>452</fpage>–<lpage>462</lpage>.<pub-id pub-id-type="pmid">24886017</pub-id></mixed-citation>
</ref>
<ref id="bibr90-2470547020924844">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Buitelaar</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD.</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet. <year>2008</year>; 
<volume>147B</volume>: <fpage>1481</fpage>–<lpage>1487</lpage>.<pub-id pub-id-type="pmid">18553640</pub-id></mixed-citation>
</ref>
<ref id="bibr91-2470547020924844">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>VW</given-names></name><name><surname>Addington</surname><given-names>A</given-names></name><name><surname>Hyman</surname><given-names>A.</given-names></name></person-group>
<article-title>Novel autism subtype-dependent genetic variants are revealed by quantitative trait and subphenotype association analyses of published GWAS data.</article-title>
<source/>PLoS One. <year>2011</year>; 
<volume>6</volume>: <fpage>e19067</fpage>.<pub-id pub-id-type="pmid">21556359</pub-id></mixed-citation>
</ref>
<ref id="bibr92-2470547020924844">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>VW</given-names></name><name><surname>Steinberg</surname><given-names>ME.</given-names></name></person-group>
<article-title>Novel clustering of items from the autism diagnostic interview-revised to define phenotypes within autism spectrum disorders.</article-title>
<source/>Autism Res. <year>2009</year>; 
<volume>2</volume>: <fpage>67</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">19455643</pub-id></mixed-citation>
</ref>
<ref id="bibr93-2470547020924844">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>XQ</given-names></name><name><surname>Paterson</surname><given-names>AD</given-names></name><name><surname>Szatmari</surname><given-names>P.</given-names></name></person-group>
<article-title>Genome-wide linkage analyses of quantitative and categorical autism subphenotypes.</article-title>
<source/>Biol Psychiatry. <year>2008</year>; 
<volume>64</volume>: <fpage>561</fpage>–<lpage>570</lpage>.<pub-id pub-id-type="pmid">18632090</pub-id></mixed-citation>
</ref>
<ref id="bibr94-2470547020924844">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandell</surname><given-names>DS</given-names></name><name><surname>Novak</surname><given-names>MM</given-names></name><name><surname>Zubritsky</surname><given-names>CD.</given-names></name></person-group>
<article-title>Factors associated with age of diagnosis among children with autism spectrum disorders.</article-title>
<source/>Pediatrics. <year>2005</year>; 
<volume>116</volume>: <fpage>1480</fpage>–<lpage>1486</lpage>.<pub-id pub-id-type="pmid">16322174</pub-id></mixed-citation>
</ref>
<ref id="bibr95-2470547020924844">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masi</surname><given-names>A</given-names></name><name><surname>DeMayo</surname><given-names>MM</given-names></name><name><surname>Glozier</surname><given-names>N</given-names></name><name><surname>Guastella</surname><given-names>AJ.</given-names></name></person-group>
<article-title>An overview of autism spectrum disorder, heterogeneity and treatment options.</article-title>
<source/>Neurosci Bull. <year>2017</year>; 
<volume>33</volume>: <fpage>183</fpage>–<lpage>193</lpage>.<pub-id pub-id-type="pmid">28213805</pub-id></mixed-citation>
</ref>
<ref id="bibr96-2470547020924844">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaste</surname><given-names>P</given-names></name><name><surname>Klei</surname><given-names>L</given-names></name><name><surname>Sanders</surname><given-names>SJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>A genome-wide association study of autism using the Simons Simplex Collection: does reducing phenotypic heterogeneity in autism increase genetic homogeneity?</article-title>
<source/>Biol Psychiatry. <year>2015</year>; 
<volume>77</volume>: <fpage>775</fpage>–<lpage>784</lpage>.<pub-id pub-id-type="pmid">25534755</pub-id></mixed-citation>
</ref>
<ref id="bibr97-2470547020924844">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gollwitzer</surname><given-names>A</given-names></name><name><surname>Bargh</surname><given-names>JA.</given-names></name></person-group>
<article-title>Social psychological skill and its correlates</article-title>. <source/>Social Psychology. <year>2018</year>; 
<volume>49</volume>: <fpage>88</fpage>–<lpage>102</lpage>.</mixed-citation>
</ref>
<ref id="bibr98-2470547020924844">
<label>98</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Gollwitzer</surname><given-names>A</given-names></name><name><surname>Martel</surname><given-names>C</given-names></name><name><surname>McPartland</surname><given-names>JC</given-names></name><name><surname>Bargh</surname><given-names>JA.</given-names></name></person-group> Autism spectrum traits predict higher social psychological skill. <italic>Proc Natl Acad Sci U S A</italic>
<year>2019</year>; 16: 19245–19247.</mixed-citation>
</ref>
<ref id="bibr99-2470547020924844">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faridi</surname><given-names>F</given-names></name><name><surname>Khosrowabadi</surname><given-names>R.</given-names></name></person-group>
<article-title>Behavioral, cognitive and neural markers of asperger syndrome.</article-title>
<source/>Basic Clin Neurosci. <year>2017</year>; 
<volume>8</volume>: <fpage>349</fpage>–<lpage>359</lpage>.<pub-id pub-id-type="pmid">29167722</pub-id></mixed-citation>
</ref>
<ref id="bibr100-2470547020924844">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kern</surname><given-names>JK</given-names></name><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Sykes</surname><given-names>LK</given-names></name><name><surname>Geier</surname><given-names>MR</given-names></name><name><surname>Deth</surname><given-names>RC.</given-names></name></person-group>
<article-title>Are ASD and ADHD a continuum? A comparison of pathophysiological similarities between the disorders.</article-title>
<source/>J Atten Disord. <year>2015</year>; 
<volume>19</volume>: <fpage>805</fpage>–<lpage>827</lpage>.<pub-id pub-id-type="pmid">23074304</pub-id></mixed-citation>
</ref>
<ref id="bibr101-2470547020924844">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>EB</given-names></name><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Anckarsater</surname><given-names>H</given-names></name><name><surname>Happe</surname><given-names>F</given-names></name><name><surname>Ronald</surname><given-names>A.</given-names></name></person-group>
<article-title>Examining and interpreting the female protective effect against autistic behavior.</article-title>
<source/>Proc Natl Acad Sci U S A. <year>2013</year>; 
<volume>110</volume>: <fpage>5258</fpage>–<lpage>5262</lpage>.<pub-id pub-id-type="pmid">23431162</pub-id></mixed-citation>
</ref>
<ref id="bibr102-2470547020924844">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name></person-group>
<article-title>The extreme male brain theory of autism</article-title>. <source/>Trends Cogn Sci. <year>2002</year>; 
<volume>6</volume>: <fpage>248</fpage>–<lpage>254</lpage>.<pub-id pub-id-type="pmid">12039606</pub-id></mixed-citation>
</ref>
<ref id="bibr103-2470547020924844">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Kern</surname><given-names>JK</given-names></name><name><surname>King</surname><given-names>PG</given-names></name><name><surname>Sykes</surname><given-names>LK</given-names></name><name><surname>Geier</surname><given-names>MR.</given-names></name></person-group>
<article-title>An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders.</article-title>
<source/>Acta Neurobiol Exp (Wars). <year>2012</year>; 
<volume>72</volume>: <fpage>1</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">22508080</pub-id></mixed-citation>
</ref>
<ref id="bibr104-2470547020924844">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name></person-group>
<article-title>Autism: the empathizing-systemizing (E-S) theory.</article-title>
<source/>Ann N Y Acad Sci. <year>2009</year>; 
<volume>1156</volume>: <fpage>68</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">19338503</pub-id></mixed-citation>
</ref>
<ref id="bibr105-2470547020924844">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S</given-names></name><name><surname>Golan</surname><given-names>O</given-names></name><name><surname>Ashwin</surname><given-names>E.</given-names></name></person-group>
<article-title>Can emotion recognition be taught to children with autism spectrum conditions?</article-title>
<source/>Philos Trans R Soc Lond B Biol Sci. <year>2009</year>; 
<volume>364</volume>: <fpage>3567</fpage>–<lpage>3574</lpage>.<pub-id pub-id-type="pmid">19884151</pub-id></mixed-citation>
</ref>
<ref id="bibr106-2470547020924844">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wendt</surname><given-names>FR</given-names></name><name><surname>Muniz Carvalho</surname><given-names>C</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Polimanti</surname><given-names>R.</given-names></name></person-group>
<article-title>The effect of the genetic liability to autism spectrum disorder on emotion recognition in young unaffected probands from a population-based cohort</article-title>. <source/>medRxiv. <year>2019</year>; <fpage>19001230</fpage>.</mixed-citation>
</ref>
<ref id="bibr107-2470547020924844">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name></person-group>, <etal>et al</etal>
<article-title>Association of genetic risks with autism spectrum disorder and early neurodevelopmental delays among children without intellectual disability</article-title>. <source/>JAMA Netw Open. <year>2020</year>; 
<volume>3</volume>: <fpage>e1921644</fpage>.<pub-id pub-id-type="pmid">32031653</pub-id></mixed-citation>
</ref>
<ref id="bibr108-2470547020924844">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannon</surname><given-names>E</given-names></name><name><surname>Schendel</surname><given-names>D</given-names></name><name><surname>Ladd-Acosta</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>
<article-title>Elevated polygenic burden for autism is associated with differential DNA methylation at birth.</article-title>
<source/>Genome Med. <year>2018</year>; 
<volume>10</volume>: <fpage>19</fpage>.<pub-id pub-id-type="pmid">29587883</pub-id></mixed-citation>
</ref>
<ref id="bibr109-2470547020924844">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranlund</surname><given-names>S</given-names></name><name><surname>Rosa</surname><given-names>MJ</given-names></name><name><surname>de Jong</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>
<article-title>Associations between polygenic risk scores for four psychiatric illnesses and brain structure using multivariate pattern recognition.</article-title>
<source/>Neuroimage Clin. <year>2018</year>; 
<volume>20</volume>: <fpage>1026</fpage>–<lpage>1036</lpage>.<pub-id pub-id-type="pmid">30340201</pub-id></mixed-citation>
</ref>
<ref id="bibr110-2470547020924844">
<label>110</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>AG</given-names></name><name><surname>Dieleman</surname><given-names>GC</given-names></name><name><surname>Jansen</surname><given-names>PR</given-names></name><name><surname>Verhulst</surname><given-names>FC</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>Polderman</surname><given-names>TJC.</given-names></name></person-group> Psychiatric polygenic risk scores as predictor for attention deficit/hyperactivity disorder and autism spectrum disorder in a clinical child and adolescent sample. <italic>Behav Genet</italic>
<year>2019</year>.</mixed-citation>
</ref>
<ref id="bibr111-2470547020924844">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>RB</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name><name><surname>Chou</surname><given-names>SP</given-names></name></person-group>, <etal>et al</etal>
<article-title>The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III</article-title>. <source/>Soc Psychiatry Psychiatr Epidemiol. <year>2016</year>; 
<volume>51</volume>: <fpage>1137</fpage>–<lpage>1148</lpage>.<pub-id pub-id-type="pmid">27106853</pub-id></mixed-citation>
</ref>
<ref id="bibr112-2470547020924844">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolin</surname><given-names>DF</given-names></name><name><surname>Foa</surname><given-names>EB.</given-names></name></person-group>
<article-title>Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research.</article-title>
<source/>Psychol Bull. <year>2006</year>; 
<volume>132</volume>: <fpage>959</fpage>–<lpage>992</lpage>.<pub-id pub-id-type="pmid">17073529</pub-id></mixed-citation>
</ref>
<ref id="bibr113-2470547020924844">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Aguilar-Gaxiola</surname><given-names>S</given-names></name><name><surname>Alonso</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>
<article-title>Trauma and PTSD in the WHO World Mental Health Surveys.</article-title>
<source/>Eur J Psychotraumatol. <year>2017</year>; 
<volume>8</volume>: <fpage>1353383</fpage>.<pub-id pub-id-type="pmid">29075426</pub-id></mixed-citation>
</ref>
<ref id="bibr114-2470547020924844">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>LE</given-names></name><name><surname>Ratanatharathorn</surname><given-names>A</given-names></name><name><surname>Aiello</surname><given-names>AE</given-names></name></person-group>, <etal>et al</etal>
<article-title>Largest GWAS of PTSD (N 070) yields genetic overlap with schizophrenia and sex differences in heritability.</article-title>
<source/>Mol Psychiatry. <year>2018</year>; 
<volume>23</volume>: <fpage>666</fpage>–<lpage>673</lpage>.<pub-id pub-id-type="pmid">28439101</pub-id></mixed-citation>
</ref>
<ref id="bibr115-2470547020924844">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galatzer-Levy</surname><given-names>IR</given-names></name><name><surname>Bryant</surname><given-names>RA.</given-names></name></person-group>
<article-title>636,120 Ways to have posttraumatic stress disorder.</article-title>
<source/>Perspect Psychol Sci. <year>2013</year>; 
<volume>8</volume>: <fpage>651</fpage>–<lpage>662</lpage>.<pub-id pub-id-type="pmid">26173229</pub-id></mixed-citation>
</ref>
<ref id="bibr116-2470547020924844">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimerling</surname><given-names>R</given-names></name><name><surname>Allen</surname><given-names>MC</given-names></name><name><surname>Duncan</surname><given-names>LE.</given-names></name></person-group>
<article-title>Chromosomes to social contexts: sex and gender differences in PTSD.</article-title>
<source/>Curr Psychiatry Rep. <year>2018</year>; 
<volume>20</volume>: <fpage>114</fpage>.<pub-id pub-id-type="pmid">30345456</pub-id></mixed-citation>
</ref>
<ref id="bibr117-2470547020924844">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>SR</given-names></name><name><surname>Ratanatharathorn</surname><given-names>A</given-names></name><name><surname>Lai</surname><given-names>BS</given-names></name></person-group>, <etal>et al</etal>
<article-title>Posttraumatic stress disorder symptom trajectories within the first year following emergency department admissions: pooled results from the International Consortium to predict PTSD</article-title>. <source/>Psychol Med. <year>2020</year>: <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
</ref>
<ref id="bibr118-2470547020924844">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasin</surname><given-names>DS</given-names></name><name><surname>Sarvet</surname><given-names>AL</given-names></name><name><surname>Meyers</surname><given-names>JL</given-names></name></person-group>, <etal>et al</etal>
<article-title>Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States.</article-title>
<source/>JAMA Psychiatry. <year>2018</year>; 
<volume>75</volume>: <fpage>336</fpage>–<lpage>346</lpage>.<pub-id pub-id-type="pmid">29450462</pub-id></mixed-citation>
</ref>
<ref id="bibr119-2470547020924844">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Kendler</surname><given-names>KS.</given-names></name></person-group>
<article-title>Genetic epidemiology of major depression: review and meta-analysis.</article-title>
<source/>Am J Psychiatry. <year>2000</year>; 
<volume>157</volume>: <fpage>1552</fpage>–<lpage>1562</lpage>.<pub-id pub-id-type="pmid">11007705</pub-id></mixed-citation>
</ref>
<ref id="bibr120-2470547020924844">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Streit</surname><given-names>F</given-names></name><name><surname>Treutlein</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>
<article-title>Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist.</article-title>
<source/>Psychiatr Genet. <year>2017</year>; 
<volume>27</volume>: <fpage>187</fpage>–<lpage>196</lpage>.<pub-id pub-id-type="pmid">28731911</pub-id></mixed-citation>
</ref>
<ref id="bibr121-2470547020924844">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>DM</given-names></name><name><surname>Adams</surname><given-names>MJ</given-names></name><name><surname>Shirali</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study of depression phenotypes in UK biobank identifies variants in excitatory synaptic pathways</article-title>. <source/>Nat Commun. <year>2018</year>; 
<volume>9</volume>: <fpage>1470</fpage>.<pub-id pub-id-type="pmid">29662059</pub-id></mixed-citation>
</ref>
<ref id="bibr122-2470547020924844">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyde</surname><given-names>CL</given-names></name><name><surname>Nagle</surname><given-names>MW</given-names></name><name><surname>Tian</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>
<article-title>Identification of 15 genetic loci associated with risk of major depression in individuals of European descent</article-title>. <source/>Nat Genet. <year>2016</year>; 
<volume>48</volume>: <fpage>1031</fpage>–<lpage>1036</lpage>.<pub-id pub-id-type="pmid">27479909</pub-id></mixed-citation>
</ref>
<ref id="bibr123-2470547020924844">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Lewis</surname><given-names>CM</given-names></name></person-group>, <etal>et al</etal>
<article-title>A mega-analysis of genome-wide association studies for major depressive disorder</article-title>. <source/>Mol Psychiatry. <year>2013</year>; 
<volume>18</volume>: <fpage>497</fpage>–<lpage>511</lpage>.<pub-id pub-id-type="pmid">22472876</pub-id></mixed-citation>
</ref>
<ref id="bibr124-2470547020924844">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trzaskowski</surname><given-names>M</given-names></name><name><surname>Mehta</surname><given-names>D</given-names></name><name><surname>Peyrot</surname><given-names>WJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>Quantifying between-cohort and between-sex genetic heterogeneity in major depressive disorder.</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet. <year>2019</year>; 
<volume>180</volume>: <fpage>439</fpage>–<lpage>447</lpage>.<pub-id pub-id-type="pmid">30708398</pub-id></mixed-citation>
</ref>
<ref id="bibr125-2470547020924844">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardno</surname><given-names>AG</given-names></name><name><surname>Owen</surname><given-names>MJ.</given-names></name></person-group>
<article-title>Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder.</article-title>
<source/>Schizophr Bull. <year>2014</year>; 
<volume>40</volume>: <fpage>504</fpage>–<lpage>515</lpage>.<pub-id pub-id-type="pmid">24567502</pub-id></mixed-citation>
</ref>
<ref id="bibr126-2470547020924844">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Martins</surname><given-names>SS</given-names></name><name><surname>Nestadt</surname><given-names>G</given-names></name><name><surname>Bienvenu</surname><given-names>OJ</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Alexandre</surname><given-names>P.</given-names></name></person-group>
<article-title>The burden of mental disorders.</article-title>
<source/>Epidemiol Rev. <year>2008</year>; 
<volume>30</volume>: <fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">18806255</pub-id></mixed-citation>
</ref>
<ref id="bibr127-2470547020924844">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khramtsova</surname><given-names>EA</given-names></name><name><surname>Heldman</surname><given-names>R</given-names></name><name><surname>Derks</surname><given-names>EM</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Davis</surname><given-names>LK</given-names></name><name><surname>Stranger</surname><given-names>BE.</given-names></name></person-group>
<article-title>Sex differences in the genetic architecture of obsessive-compulsive disorder.</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet. <year>2019</year>; 
<volume>180</volume>: <fpage>351</fpage>–<lpage>364</lpage>.<pub-id pub-id-type="pmid">30456828</pub-id></mixed-citation>
</ref>
<ref id="bibr128-2470547020924844">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>HA</given-names></name><name><surname>Gair</surname><given-names>SL</given-names></name><name><surname>Scharf</surname><given-names>JM</given-names></name><name><surname>Grice</surname><given-names>DE.</given-names></name></person-group>
<article-title>Genetics of obsessive-compulsive disorder and related disorders.</article-title>
<source/>Psychiatr Clin North Am. <year>2014</year>; 
<volume>37</volume>: <fpage>319</fpage>–<lpage>335</lpage>.<pub-id pub-id-type="pmid">25150565</pub-id></mixed-citation>
</ref>
<ref id="bibr129-2470547020924844">
<label>129</label>
<mixed-citation publication-type="journal">International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS). 
<article-title>Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis</article-title>. <source/>Mol Psychiatry. <year>2018</year>; 
<volume>23</volume>: <fpage>1181</fpage>–<lpage>1188</lpage>.<pub-id pub-id-type="pmid">28761083</pub-id></mixed-citation>
</ref>
<ref id="bibr130-2470547020924844">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattina</surname><given-names>GF</given-names></name><name><surname>Steiner</surname><given-names>M.</given-names></name></person-group>
<article-title>The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: overview.</article-title>
<source/>Prog Neuropsychopharmacol Biol Psychiatry. <year>2016</year>; 
<volume>67</volume>: <fpage>107</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">26827635</pub-id></mixed-citation>
</ref>
<ref id="bibr131-2470547020924844">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>LK</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Keenan</surname><given-names>CL</given-names></name></person-group>, <etal>et al</etal>
<article-title>Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture</article-title>. <source/>PLoS Genet. <year>2013</year>; 
<volume>9</volume>: <fpage>e1003864</fpage>.<pub-id pub-id-type="pmid">24204291</pub-id></mixed-citation>
</ref>
<ref id="bibr132-2470547020924844">
<label>132</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>MH</given-names></name><name><surname>Cheng</surname><given-names>CM</given-names></name><name><surname>Tsai</surname><given-names>SJ</given-names></name></person-group>, <etal>et al</etal> Familial coaggregation of major psychiatric disorders among first-degree relatives of patients with obsessive-compulsive disorder: a nationwide study. <italic>Psychol Med</italic>
<year>2020</year>: 1–8.</mixed-citation>
</ref>
<ref id="bibr133-2470547020924844">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costas</surname><given-names>J</given-names></name><name><surname>Carrera</surname><given-names>N</given-names></name><name><surname>Alonso</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>
<article-title>Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia.</article-title>
<source/>Transl Psychiatry. <year>2016</year>; 
<volume>6</volume>: <fpage>e768</fpage>.<pub-id pub-id-type="pmid">27023174</pub-id></mixed-citation>
</ref>
<ref id="bibr134-2470547020924844">
<label>134</label>
<mixed-citation publication-type="other">Neurodevelopmental Disorders. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. May 2013.</mixed-citation>
</ref>
<ref id="bibr135-2470547020924844">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>MM.</given-names></name></person-group>
<article-title>The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies</article-title>. <source/>J Psychosom Res. <year>2008</year>; 
<volume>65</volume>: <fpage>461</fpage>–<lpage>472</lpage>.<pub-id pub-id-type="pmid">18940377</pub-id></mixed-citation>
</ref>
<ref id="bibr136-2470547020924844">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalifa</surname><given-names>N</given-names></name><name><surname>von Knorring</surname><given-names>AL.</given-names></name></person-group>
<article-title>Prevalence of tic disorders and Tourette syndrome in a Swedish school population</article-title>. <source/>Dev Med Child Neurol. <year>2003</year>; 
<volume>45</volume>: <fpage>315</fpage>–<lpage>319</lpage>.<pub-id pub-id-type="pmid">12729145</pub-id></mixed-citation>
</ref>
<ref id="bibr137-2470547020924844">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scahill</surname><given-names>L</given-names></name><name><surname>Specht</surname><given-names>M</given-names></name><name><surname>Page</surname><given-names>C.</given-names></name></person-group>
<article-title>The prevalence of tic disorders and clinical characteristics in children.</article-title>
<source/>J Obsessive Compuls Relat Disord. <year>2014</year>; 
<volume>3</volume>: <fpage>394</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">25436183</pub-id></mixed-citation>
</ref>
<ref id="bibr138-2470547020924844">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichter</surname><given-names>DG</given-names></name><name><surname>Finnegan</surname><given-names>SG.</given-names></name></person-group>
<article-title>Influence of gender on Tourette syndrome beyond adolescence.</article-title>
<source/>Eur Psychiatry. <year>2015</year>; 
<volume>30</volume>: <fpage>334</fpage>–<lpage>340</lpage>.<pub-id pub-id-type="pmid">25193042</pub-id></mixed-citation>
</ref>
<ref id="bibr139-2470547020924844">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>MM.</given-names></name></person-group>
<article-title>Movement disorders: Tourette syndrome–beyond swearing and sex?</article-title>
<source/>Nat Rev Neurol. <year>2014</year>; 
<volume>10</volume>: <fpage>6</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">24296654</pub-id></mixed-citation>
</ref>
<ref id="bibr140-2470547020924844">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>MM.</given-names></name></person-group>
<article-title>A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies</article-title>. <source/>Lancet Psychiatry. <year>2015</year>; 
<volume>2</volume>: <fpage>68</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">26359614</pub-id></mixed-citation>
</ref>
<ref id="bibr141-2470547020924844">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>S</given-names></name><name><surname>Walkup</surname><given-names>JT</given-names></name><name><surname>Woods</surname><given-names>DW</given-names></name></person-group>, <etal>et al</etal>
<article-title>Detecting a clinically meaningful change in tic severity in Tourette syndrome: a comparison of three methods.</article-title>
<source/>Contemp Clin Trials. <year>2013</year>; 
<volume>36</volume>: <fpage>414</fpage>–<lpage>420</lpage>.<pub-id pub-id-type="pmid">24001701</pub-id></mixed-citation>
</ref>
<ref id="bibr142-2470547020924844">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>PH</given-names></name></person-group>, <etal>et al</etal>
<article-title>Cross-disorder GWAS meta-analysis for attention deficit/hyperactivity disorder, autism spectrum disorder, obsessive compulsive disorder, and Tourette syndrome</article-title><source/>. bioRxiv. <year>2019</year>; <fpage>770222</fpage>.</mixed-citation>
</ref>
<ref id="bibr143-2470547020924844">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darrow</surname><given-names>SM</given-names></name><name><surname>Hirschtritt</surname><given-names>ME</given-names></name><name><surname>Davis</surname><given-names>LK</given-names></name></person-group>, <etal>et al</etal>
<article-title>Identification of two heritable cross-disorder endophenotypes for Tourette syndrome.</article-title>
<source/>Am J Psychiatry. <year>2017</year>; 
<volume>174</volume>: <fpage>387</fpage>–<lpage>396</lpage>.<pub-id pub-id-type="pmid">27809572</pub-id></mixed-citation>
</ref>
<ref id="bibr144-2470547020924844">
<label>144</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Angermeyer</surname><given-names>M</given-names></name><name><surname>Anthony</surname><given-names>JC</given-names></name></person-group>, <etal>et al</etal>
<article-title>Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative</article-title>. <source/>World Psychiatry. <year>2007</year>; 
<volume>6</volume>: <fpage>168</fpage>–<lpage>176</lpage>.<pub-id pub-id-type="pmid">18188442</pub-id></mixed-citation>
</ref>
<ref id="bibr145-2470547020924844">
<label>145</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somers</surname><given-names>JM</given-names></name><name><surname>Goldner</surname><given-names>EM</given-names></name><name><surname>Waraich</surname><given-names>P</given-names></name><name><surname>Hsu</surname><given-names>L.</given-names></name></person-group>
<article-title>Prevalence and incidence studies of anxiety disorders: a systematic review of the literature.</article-title>
<source/>Can J Psychiatry. <year>2006</year>; 
<volume>51</volume>: <fpage>100</fpage>–<lpage>113</lpage>.<pub-id pub-id-type="pmid">16989109</pub-id></mixed-citation>
</ref>
<ref id="bibr146-2470547020924844">
<label>146</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>MN</given-names></name><name><surname>Verdi</surname><given-names>S</given-names></name><name><surname>Burri</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>
<article-title>Generalised anxiety disorder – a twin study of genetic architecture, genome-wide association and differential gene expression.</article-title>
<source/>PLoS One. <year>2015</year>; 
<volume>10</volume>: <fpage>e0134865</fpage>.<pub-id pub-id-type="pmid">26274327</pub-id></mixed-citation>
</ref>
<ref id="bibr147-2470547020924844">
<label>147</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>CP</given-names></name><name><surname>Asnaani</surname><given-names>A</given-names></name><name><surname>Litz</surname><given-names>BT</given-names></name><name><surname>Hofmann</surname><given-names>SG.</given-names></name></person-group>
<article-title>Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness.</article-title>
<source/>J Psychiatr Res. <year>2011</year>; 
<volume>45</volume>: <fpage>1027</fpage>–10<lpage>35</lpage>.<pub-id pub-id-type="pmid">21439576</pub-id></mixed-citation>
</ref>
<ref id="bibr148-2470547020924844">
<label>148</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldao</surname><given-names>A</given-names></name><name><surname>Mennin</surname><given-names>DS</given-names></name><name><surname>Linardatos</surname><given-names>E</given-names></name><name><surname>Fresco</surname><given-names>DM.</given-names></name></person-group>
<article-title>Differential patterns of physical symptoms and subjective processes in generalized anxiety disorder and unipolar depression.</article-title>
<source/>J Anxiety Disord. <year>2010</year>; 
<volume>24</volume>: <fpage>250</fpage>–<lpage>259</lpage>.<pub-id pub-id-type="pmid">20060680</pub-id></mixed-citation>
</ref>
<ref id="bibr149-2470547020924844">
<label>149</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culpepper</surname><given-names>L.</given-names></name></person-group>
<article-title>Generalized anxiety disorder and medical illness.</article-title>
<source/>J Clin Psychiatry. <year>2009</year>; 
<volume>70</volume>(<issue>Suppl 2</issue>): <fpage>20</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">19371503</pub-id></mixed-citation>
</ref>
<ref id="bibr150-2470547020924844">
<label>150</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mussell</surname><given-names>M</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Herzog</surname><given-names>W</given-names></name><name><surname>Lowe</surname><given-names>B.</given-names></name></person-group>
<article-title>Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety</article-title>. <source/>J Psychosom Res. <year>2008</year>; 
<volume>64</volume>: <fpage>605</fpage>–<lpage>612</lpage>.<pub-id pub-id-type="pmid">18501261</pub-id></mixed-citation>
</ref>
<ref id="bibr151-2470547020924844">
<label>151</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otowa</surname><given-names>T</given-names></name><name><surname>Hek</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>
<article-title>Meta-analysis of genome-wide association studies of anxiety disorders.</article-title>
<source/>Mol Psychiatry. <year>2016</year>; 
<volume>21</volume>: <fpage>1391</fpage>–<lpage>1399</lpage>.<pub-id pub-id-type="pmid">26754954</pub-id></mixed-citation>
</ref>
<ref id="bibr152-2470547020924844">
<label>152</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Purves</surname><given-names>KL</given-names></name><name><surname>Coleman</surname><given-names>JRI</given-names></name><name><surname>Meier</surname><given-names>SM</given-names></name></person-group>, <etal>et al</etal> A major role for common genetic variation in anxiety disorders. <italic>Mol Psychiatry</italic>
<year>2019</year>.</mixed-citation>
</ref>
<ref id="bibr153-2470547020924844">
<label>153</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flint</surname><given-names>AJ</given-names></name><name><surname>Peasley-Miklus</surname><given-names>C</given-names></name><name><surname>Papademetriou</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>
<article-title>Effect of age on the frequency of anxiety disorders in major depression with psychotic features.</article-title>
<source/>Am J Geriatr Psychiatry. <year>2010</year>; 
<volume>18</volume>: <fpage>404</fpage>–<lpage>412</lpage>.<pub-id pub-id-type="pmid">20429084</pub-id></mixed-citation>
</ref>
<ref id="bibr154-2470547020924844">
<label>154</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenze</surname><given-names>EJ</given-names></name><name><surname>Wetherell</surname><given-names>JL.</given-names></name></person-group>
<article-title>A lifespan view of anxiety disorders</article-title>. <source/>Dialogues Clin Neurosci. <year>2011</year>; 
<volume>13</volume>: <fpage>381</fpage>–<lpage>399</lpage>.<pub-id pub-id-type="pmid">22275845</pub-id></mixed-citation>
</ref>
<ref id="bibr155-2470547020924844">
<label>155</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>LC</given-names></name><name><surname>Heimberg</surname><given-names>RG</given-names></name><name><surname>Blanco</surname><given-names>C</given-names></name><name><surname>Schneier</surname><given-names>FR</given-names></name><name><surname>Liebowitz</surname><given-names>MR.</given-names></name></person-group>
<article-title>Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy.</article-title>
<source/>Depress Anxiety. <year>2012</year>; 
<volume>29</volume>: <fpage>131</fpage>–<lpage>138</lpage>.<pub-id pub-id-type="pmid">22065560</pub-id></mixed-citation>
</ref>
<ref id="bibr156-2470547020924844">
<label>156</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iffland</surname><given-names>B</given-names></name><name><surname>Sansen</surname><given-names>LM</given-names></name><name><surname>Catani</surname><given-names>C</given-names></name><name><surname>Neuner</surname><given-names>F.</given-names></name></person-group>
<article-title>Emotional but not physical maltreatment is independently related to psychopathology in subjects with various degrees of social anxiety: a web-based internet survey.</article-title>
<source/>BMC Psychiatry. <year>2012</year>; 
<volume>12</volume>: <fpage>49</fpage>.<pub-id pub-id-type="pmid">22632167</pub-id></mixed-citation>
</ref>
<ref id="bibr157-2470547020924844">
<label>157</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>MB</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Gelernter</surname><given-names>J.</given-names></name></person-group>
<article-title>Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders.</article-title>
<source/>Neuropsychopharmacology. <year>2008</year>; 
<volume>33</volume>: <fpage>312</fpage>–<lpage>319</lpage>.<pub-id pub-id-type="pmid">17460615</pub-id></mixed-citation>
</ref>
<ref id="bibr158-2470547020924844">
<label>158</label>
<mixed-citation publication-type="other"><collab>Centers for Disease Control and Prevention. <italic>Web-Based Injury Statistics Query and Reporting System (WISQARS)</italic></collab>. Atlanta, GA: Author; <year>2013</year>.</mixed-citation>
</ref>
<ref id="bibr159-2470547020924844">
<label>159</label>
<mixed-citation publication-type="other"><collab>Centers for Disease Control and Prevention. <italic>Suicide Facts at a Glance</italic></collab>. Atlanta, GA: Author; <year>2015</year>.</mixed-citation>
</ref>
<ref id="bibr160-2470547020924844">
<label>160</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradvik</surname><given-names>L.</given-names></name></person-group>
<article-title>Suicide risk and mental disorders</article-title>. <source/>Int J Environ Res Public Health. <year>2018</year>; 
<volume>15</volume>.</mixed-citation>
</ref>
<ref id="bibr161-2470547020924844">
<label>161</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name><name><surname>Pedersen</surname><given-names>CB.</given-names></name></person-group>
<article-title>Absolute risk of suicide after first hospital contact in mental disorder.</article-title>
<source/>Arch Gen Psychiatry. <year>2011</year>; 
<volume>68</volume>: <fpage>1058</fpage>–10<lpage>64</lpage>.<pub-id pub-id-type="pmid">21969462</pub-id></mixed-citation>
</ref>
<ref id="bibr162-2470547020924844">
<label>162</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>JJ</given-names></name><name><surname>Waternaux</surname><given-names>C</given-names></name><name><surname>Haas</surname><given-names>GL</given-names></name><name><surname>Malone</surname><given-names>KM.</given-names></name></person-group>
<article-title>Toward a clinical model of suicidal behavior in psychiatric patients</article-title>. <source/>Am J Psychiatry. <year>1999</year>; 
<volume>156</volume>: <fpage>181</fpage>–18<lpage>9</lpage>.<pub-id pub-id-type="pmid">9989552</pub-id></mixed-citation>
</ref>
<ref id="bibr163-2470547020924844">
<label>163</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zai</surname><given-names>CC</given-names></name><name><surname>de Luca</surname><given-names>V</given-names></name><name><surname>Strauss</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>RP</given-names></name><name><surname>Sakinofsky</surname><given-names>I</given-names></name><name><surname>Kennedy</surname><given-names>JL.</given-names></name></person-group>
<chapter-title>Genetic factors and suicidal behavior</chapter-title> In: <person-group person-group-type="editor"><name><surname>Dwivedi</surname><given-names>Y</given-names></name></person-group>, ed. <source/>The Neurobiological Basis of Suicide. 
<publisher-loc>Boca Raton, FL</publisher-loc>: CRC Press/Taylor &amp; Francis; <year>2012</year>.</mixed-citation>
</ref>
<ref id="bibr164-2470547020924844">
<label>164</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>N</given-names></name><name><surname>Bigdeli</surname><given-names>TB</given-names></name><name><surname>Borglum</surname><given-names>AD</given-names></name></person-group>, <etal>et al</etal>
<article-title>GWAS of suicide attempt in psychiatric disorders and association with major depression polygenic risk scores.</article-title>
<source/>Am J Psychiatry. <year>2019</year>; 
<volume>176</volume>: <fpage>651</fpage>–6<lpage>60</lpage>.<pub-id pub-id-type="pmid">31164008</pub-id></mixed-citation>
</ref>
<ref id="bibr165-2470547020924844">
<label>165</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname><given-names>I</given-names></name><name><surname>Akiyama</surname><given-names>M</given-names></name><name><surname>Shirakawa</surname><given-names>O</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association studies identify polygenic effects for completed suicide in the Japanese population</article-title>. <source/>Neuropsychopharmacology. <year>2019</year>; 
<volume>44</volume>: <fpage>2119</fpage>–<lpage>2124</lpage>.<pub-id pub-id-type="pmid">31476763</pub-id></mixed-citation>
</ref>
<ref id="bibr166-2470547020924844">
<label>166</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Ward</surname><given-names>J</given-names></name><name><surname>Ferguson</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>
<article-title>Identification of novel genome-wide associations for suicidality in UK biobank, genetic correlation with psychiatric disorders and polygenic association with completed suicide.</article-title>
<source/>EBioMedicine. <year>2019</year>; 
<volume>41</volume>: <fpage>517</fpage>–<lpage>525</lpage>.<pub-id pub-id-type="pmid">30745170</pub-id></mixed-citation>
</ref>
<ref id="bibr167-2470547020924844">
<label>167</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>DF</given-names></name><name><surname>Polimanti</surname><given-names>R</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genetic associations with suicide attempt severity and genetic overlap with major depression.</article-title>
<source/>Transl Psychiatry. <year>2019</year>; 
<volume>9</volume>: <fpage>22</fpage>.<pub-id pub-id-type="pmid">30655502</pub-id></mixed-citation>
</ref>
<ref id="bibr168-2470547020924844">
<label>168</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Polimanti</surname><given-names>R</given-names></name><name><surname>Levey</surname><given-names>D</given-names></name><name><surname>Pathak</surname><given-names>G</given-names></name></person-group>, <etal>et al</etal> Complex multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidal behaviors. <italic>medRxiv</italic>
<year>2020</year>; 2020.01.14.20017509.</mixed-citation>
</ref>
<ref id="bibr169-2470547020924844">
<label>169</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udo</surname><given-names>T</given-names></name><name><surname>Grilo</surname><given-names>CM.</given-names></name></person-group>
<article-title>Prevalence and correlates of DSM-5-defined eating disorders in a nationally representative sample of U.S. adults.</article-title>
<source/>Biol Psychiatry. <year>2018</year>; 
<volume>84</volume>: <fpage>345</fpage>–<lpage>354</lpage>.<pub-id pub-id-type="pmid">29859631</pub-id></mixed-citation>
</ref>
<ref id="bibr170-2470547020924844">
<label>170</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spindler</surname><given-names>A</given-names></name><name><surname>Milos</surname><given-names>G.</given-names></name></person-group>
<article-title>Links between eating disorder symptom severity and psychiatric comorbidity.</article-title>
<source/>Eat Behav. <year>2007</year>; 
<volume>8</volume>: <fpage>364</fpage>–<lpage>373</lpage>.<pub-id pub-id-type="pmid">17606234</pub-id></mixed-citation>
</ref>
<ref id="bibr171-2470547020924844">
<label>171</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breithaupt</surname><given-names>L</given-names></name><name><surname>Hubel</surname><given-names>C</given-names></name><name><surname>Bulik</surname><given-names>CM.</given-names></name></person-group>
<article-title>Updates on genome-wide association findings in eating disorders and future application to precision medicine.</article-title>
<source/>Curr Neuropharmacol. <year>2018</year>; 
<volume>16</volume>: <fpage>1102</fpage>–<lpage>1110</lpage>.<pub-id pub-id-type="pmid">29473515</pub-id></mixed-citation>
</ref>
<ref id="bibr172-2470547020924844">
<label>172</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>L</given-names></name><name><surname>Yilmaz</surname><given-names>Z</given-names></name><name><surname>Gaspar</surname><given-names>H</given-names></name></person-group>, <etal>et al</etal>
<article-title>Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa.</article-title>
<source/>Am J Psychiatry. <year>2017</year>; 
<volume>174</volume>: <fpage>850</fpage>–<lpage>858</lpage>.<pub-id pub-id-type="pmid">28494655</pub-id></mixed-citation>
</ref>
<ref id="bibr173-2470547020924844">
<label>173</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>CCY</given-names></name><name><surname>Schumann</surname><given-names>G.</given-names></name></person-group>
<article-title>Review. Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders.</article-title>
<source/>Philos Trans R Soc Lond B Biol Sci. <year>2008</year>; 
<volume>363</volume>: <fpage>3213</fpage>–<lpage>3222</lpage>.<pub-id pub-id-type="pmid">18640915</pub-id></mixed-citation>
</ref>
<ref id="bibr174-2470547020924844">
<label>174</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Polimanti</surname><given-names>R</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Johnson</surname><given-names>EC</given-names></name></person-group>, <etal>et al</etal> Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium. <italic>Mol Psychiatry</italic>
<year>2020</year>.</mixed-citation>
</ref>
<ref id="bibr175-2470547020924844">
<label>175</label>
<mixed-citation publication-type="book"><collab>Substance Abuse and Mental Health Services Administration.</collab>
<source/>CBHSQ Methodology Report. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. 
<publisher-loc>Rockville, MD</publisher-loc>: 
<publisher-name>Author</publisher-name>; <year>2016</year>.</mixed-citation>
</ref>
<ref id="bibr176-2470547020924844">
<label>176</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>GE</given-names></name><name><surname>Malhi</surname><given-names>GS</given-names></name><name><surname>Cleary</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>HM</given-names></name><name><surname>Sitharthan</surname><given-names>T.</given-names></name></person-group>
<article-title>Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: systematic review and meta-analysis.</article-title>
<source/>J Affect Disord. <year>2016</year>; 
<volume>206</volume>: <fpage>321</fpage>–<lpage>330</lpage>.<pub-id pub-id-type="pmid">27426694</pub-id></mixed-citation>
</ref>
<ref id="bibr177-2470547020924844">
<label>177</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhulst</surname><given-names>B</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Kendler</surname><given-names>KS.</given-names></name></person-group>
<article-title>The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies.</article-title>
<source/>Psychol Med. <year>2015</year>; 
<volume>45</volume>: <fpage>1061</fpage>–<lpage>1072</lpage>.<pub-id pub-id-type="pmid">25171596</pub-id></mixed-citation>
</ref>
<ref id="bibr178-2470547020924844">
<label>178</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranzler</surname><given-names>HR</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Kember</surname><given-names>RL</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations.</article-title>
<source/>Nature Communications. <year>2019</year>; 
<volume>10</volume>: <fpage>1499</fpage>.</mixed-citation>
</ref>
<ref id="bibr179-2470547020924844">
<label>179</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>DB</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Reginsson</surname><given-names>GW</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence.</article-title>
<source/>Mol Psychiatry. <year>2018</year>; 
<volume>23</volume>: <fpage>1911</fpage>–<lpage>1919</lpage>.<pub-id pub-id-type="pmid">28972577</pub-id></mixed-citation>
</ref>
<ref id="bibr180-2470547020924844">
<label>180</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Erzurumluoglu</surname><given-names>AM</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Jackson</surname><given-names>VE</given-names></name></person-group>, <etal>et al</etal> Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci. <italic>Mol Psychiatry</italic>
<year>2019</year>.</mixed-citation>
</ref>
<ref id="bibr181-2470547020924844">
<label>181</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>DB</given-names></name><name><surname>Markunas</surname><given-names>CA</given-names></name><name><surname>Bierut</surname><given-names>LJ</given-names></name><name><surname>Johnson</surname><given-names>EO.</given-names></name></person-group>
<article-title>Human genetics of addiction: new insights and future directions</article-title>. <source/>Curr Psychiatry Rep. <year>2018</year>; 
<volume>20</volume>: <fpage>8</fpage>.<pub-id pub-id-type="pmid">29504045</pub-id></mixed-citation>
</ref>
<ref id="bibr182-2470547020924844">
<label>182</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasman</surname><given-names>JA</given-names></name><name><surname>Verweij</surname><given-names>KJH</given-names></name><name><surname>Gerring</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal>
<article-title>GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability (vol 21, pg 1161, 2018)</article-title>. <source/>Nat Neurosci. <year>2019</year>; 
<volume>22</volume>: <fpage>1196</fpage>.</mixed-citation>
</ref>
<ref id="bibr183-2470547020924844">
<label>183</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minica</surname><given-names>CC</given-names></name><name><surname>Verweij</surname><given-names>KJH</given-names></name><name><surname>van der Most</surname><given-names>PJ</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association meta-analysis of age at first cannabis use</article-title>. <source/>Addiction. <year>2018</year>; 
<volume>113</volume>: <fpage>2073</fpage>–<lpage>2086</lpage>.<pub-id pub-id-type="pmid">30003630</pub-id></mixed-citation>
</ref>
<ref id="bibr184-2470547020924844">
<label>184</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherva</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Kranzler</surname><given-names>H</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks.</article-title>
<source/>JAMA Psychiatry. <year>2016</year>; 
<volume>73</volume>: <fpage>472</fpage>–<lpage>480</lpage>.<pub-id pub-id-type="pmid">27028160</pub-id></mixed-citation>
</ref>
<ref id="bibr185-2470547020924844">
<label>185</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jons</surname><given-names>WA</given-names></name><name><surname>Colby</surname><given-names>CL</given-names></name><name><surname>McElroy</surname><given-names>SL</given-names></name><name><surname>Frye</surname><given-names>MA</given-names></name><name><surname>Biernacka</surname><given-names>JM</given-names></name><name><surname>Winham</surname><given-names>SJ.</given-names></name></person-group>
<article-title>Statistical methods for testing X chromosome variant associations: application to sex-specific characteristics of bipolar disorder.</article-title>
<source/>Biol Sex Differ. <year>2019</year>; 
<volume>10</volume>: <fpage>57</fpage>.<pub-id pub-id-type="pmid">31818333</pub-id></mixed-citation>
</ref>
<ref id="bibr186-2470547020924844">
<label>186</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Luciano</surname><given-names>M</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Summers</surname><given-names>KM</given-names></name></person-group>, <etal>et al</etal> The influence of X chromosome variants on trait neuroticism. <italic>Mol Psychiatry</italic>
<year>2019</year>.</mixed-citation>
</ref>
<ref id="bibr187-2470547020924844">
<label>187</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vousooghi</surname><given-names>N</given-names></name><name><surname>Shirazi</surname><given-names>MS</given-names></name><name><surname>Goodarzi</surname><given-names>A</given-names></name><name><surname>Abharian</surname><given-names>PH</given-names></name><name><surname>Zarrindast</surname><given-names>MR.</given-names></name></person-group>
<article-title>X chromosome inactivation in opioid addicted women</article-title>. <source/>Basic Clin Neurosci. <year>2015</year>; 
<volume>6</volume>: <fpage>179</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">26904175</pub-id></mixed-citation>
</ref>
<ref id="bibr188-2470547020924844">
<label>188</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espeso-Gil</surname><given-names>S</given-names></name><name><surname>Halene</surname><given-names>T</given-names></name><name><surname>Bendl</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>
<article-title>A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons.</article-title>
<source/>Genome Med. <year>2020</year>; 
<volume>12</volume>: <fpage>19</fpage>.<pub-id pub-id-type="pmid">32075678</pub-id></mixed-citation>
</ref>
<ref id="bibr189-2470547020924844">
<label>189</label>
<mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Giusti-Rodríguez</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group>, <etal>et al</etal> Using three-dimensional regulatory chromatin interactions from adult and fetal cortex to interpret genetic results for psychiatric disorders and cognitive traits. <italic>bioRxiv</italic>
<year>2019</year>; <fpage>406330</fpage>.</mixed-citation>
</ref>
<ref id="bibr190-2470547020924844">
<label>190</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group>, <etal>et al</etal>
<article-title>Local and global chromatin interactions are altered by large genomic deletions associated with human brain development.</article-title>
<source/>Nat Commun. <year>2018</year>; 
<volume>9</volume>: <fpage>5356</fpage>.<pub-id pub-id-type="pmid">30559385</pub-id></mixed-citation>
</ref>
<ref id="bibr191-2470547020924844">
<label>191</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>JM</given-names></name><name><surname>Morris</surname><given-names>SE</given-names></name><name><surname>Hoffman</surname><given-names>RE</given-names></name></person-group>, <etal>et al</etal>
<article-title>Studying hallucinations within the NIMH RDoC framework.</article-title>
<source/>Schizophr Bull. <year>2014</year>; 
<volume>40</volume>(<issue>Suppl 4</issue>): <fpage>S295</fpage>–<lpage>S304</lpage>.<pub-id pub-id-type="pmid">24847862</pub-id></mixed-citation>
</ref>
<ref id="bibr192-2470547020924844">
<label>192</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>RE</given-names></name><name><surname>Kuchenbaecker</surname><given-names>K</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name></person-group>, <etal>et al</etal>
<article-title>Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations.</article-title>
<source/>Cell. <year>2019</year>; 
<volume>179</volume>: <fpage>589</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">31607513</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>